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SUMMARY
Oxidative damage is a major threat to the integrity of our genome and can lead to mutations 
or block replication if not repaired. Base excision repair (BER) is the main pathway for repair 
of oxidative lesions and is initiated by the action of a DNA glycosylase. A monofunctional 
glycosylase recognizes and excises the modified nucleotide, while a bifunctional glycosylase 
in addition possesses an intrinsic apurinic/apyrimidinic (AP) lyase activity generating a nick 
in the DNA strand. There are five DNA glycosylases acting on oxidative damage in 
eukaryotic cells; 8-oxoguanine DNA glycosylase (OGG1), endonuclease III (NTH1), and 
endonuclease VIII-like 1, 2 and 3 (NEIL1, NEIL2 and NEIL3). These enzymes are 
bifunctional with overlapping substrate specificity and knockout mouse studies reveals that 
none of them are essential for life. NEIL3 is sequentially related to the well characterized 
enzymes NEIL1 and 2, but less is known about its biochemical properties. Paper I of this 
thesis includes an expression and purification protocol for human NEIL3. NEIL3 recognizes 
and excises guanidinohydantoin (Gh) and spiroiminodihydantoin (Sp) from the genome. In 
paper II we elucidate the amino acids important for activity. NEIL1 and NEIL2 have tightly 
coupled DNA glycosylase/AP lyase activities and perform ,-elimination mechanism to 
incise DNA. NEIL3 has uncoupled activities, where the base excision is more efficient than 
the strand incision. We demonstrate that a V2P mutation changes the catalytic properties of 
NEIL3 to be similar to the activity of NEIL1 and 2. While OGG1, NTH1, NEIL1 and NEIL2 
are expressed in most tissues throughout the organism, NEIL3 expression is limited to some 
lymphatic organs and compartments of the brain harboring neural stem cells, indicating a role 
in highly proliferative tissue. Paper III shows that mouse Neil3 is responsible for repair of Gh 
and Sp lesions in single-stranded DNA (ssDNA) in thymus and spleen, where repair activity 
correlates with Neil3 expression level. In paper IV of this study, we expose young Neil3-
deficient mice to hypoxia-ischemia, to introduce cell death and activate proliferation of 
neural tissue. We find that the Neil3 deficit leads to reduced regeneration of neural tissue in 
the striatum. Further, in vitro propagated Neil3-deficient neural stem cells have a depressed 
neurogenesis and impaired ability to repair Gh and Sp lesions in ssDNA. Taken together, we 
suggest that NEIL3 has a unique role in removing hydantoin lesions from ssDNA and thereby 
promoting replication of proliferating cells.
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INTRODUCTION
‘We totally missed the possible role of … [DNA] repair although… I later came to realize 
that DNA is so precious that probably many distinct repair mechanisms would exist.’ Francis 
Crick, in Nature 1974 (Crick, 1974).
When the molecular structure of DNA was presented by James Watson and Francis Crick in 
1953 (Watson J & Crick, 1953) it was believed to be extraordinary stable in order to maintain 
the genetic information, and to pass it on for generations. Decades later it was clear that our 
DNA is very vulnerably for damage. It has been estimated that a single cell can suffer from 
up to a million lesions in one day (Lodish et al, 2004). Damage can arise after environmental 
conditions like exposure to strong sunlight and uptake of toxins through air or food, they can 
arise as a consequence of natural cellular processes like the metabolism, or they can arise 
spontaneously by nucleotide deamination and replication errors. In contrast to other 
biomolecules, DNA cannot be replaced, only repaired. 
From an evolutionary point of view, the instability of DNA is the source of diversity and 
natural selection. From a medical point of view, it is a constant threat to the organism. A 
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large number of cancers and genetic diseases are linked to insufficient repair of damaged 
DNA. DNA damage accumulates with age and common for several of the repair-associated 
diseases are the phenotypes of premature aging (Niedernhofer et al, 2006). All eukaryotic 
cells are equipped with a multifaceted damage response system to counteract with the 
deleterious effects of DNA damage (figure 1). Sensing of lesions activates cell cycle 
checkpoints and arrests cell cycle progression to give time for DNA repair. Replication of 
damaged DNA can lead to fixation of mutations. To encounter the plethora of different DNA 
lesions, an intricate network of repair through different pathways has evolved. If the extent of 
damage is too severe to be repaired, the cell may commit suicide by entering apoptosis, for 
the benefit of the organism. Cells are also equipped with damage-tolerant translesion DNA 
polymerases bypassing a broad range of lesions, allowing DNA replication to continue. 
However, translesion polymerases have a high propensity to insert wrong bases, generating 
mutations which are fixated upon further replication cycles. Such accumulation of mutations 
is one of the main mechanisms leading to cancer (Zahn et al, 2011; Venitt, 1996). DNA 
repair mechanisms are found in all organisms and many of the enzymes are highly conserved 
from bacteria to man.                     
Figure 1. DNA damage activates the DNA damage response. Different exogenous and 
endogenous agents can cause DNA damage which triggers the DNA damage response, 
leading to cell cycle checkpoint activation. Successful repair of the lesions leads to prolonged 
cell cycle progression and transcription, while the cell will enter apoptosis if the extent of the 
damage is too severe to be repaired. 
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Endogenous and exogenous sources for DNA damage
Living organisms are constantly exposed to various environmental agents, producing a 
variety of DNA lesions. An example is ultraviolet (UV) light inducing bulky dipyrimidine 
photoproducts in DNA. Extensive UV-exposure from the sun or from sun beds can lead to 
skin cancer (Kanavy & Gerstenblith, 2011). Another exogenous threat to genome integrity is 
ionizing radiation from cosmic rays, naturally occurring radioactive material, X-rays as well 
as artificially produced radioisotopes. Ionizing radiation can liberate electrons from 
molecules, causing a broad range of DNA lesions including damage on bases and sugars, 
interstrand crosslinks, DNA single-strand breaks (SSBs), and DNA double-strand breaks 
(DSBs) (Morgan & Sowa, 2005; Ward, 1988). DNA damaging compounds can also be 
introduced through air, water or food. Alkylating agents have potential to transfer alkyl 
groups onto DNA. A pronounced example is cigarette smoking, which kills 1,5 million 
people every year due to lung cancer caused by premutagenic DNA lesions (Proctor, 2012). 
Humans can to some extent protect themselves against the environmental mutagens, but 
damage from endogenous sources is unavoidable. An example of an endogenous alkyl donor 
is S-adenosylmethionine (SAM), a metabolite involved in many biochemical reactions. The 
high transfer potential of this methyl donor makes it prone to spontaneously methylate DNA 
(Xiao & Samson, 1993; Rydberg & Lindahl, 1982; Taverna & Sedgwick, 1996). Both N and 
O atoms in the DNA structure can be alkylated, leading to premutagenic and cytotoxic 
lesions. Water is another endogenous threat to our genome. The base-sugar bonds of DNA 
are vulnerable to hydrolytic attack, leading to apurinic/apyrimidinic (AP) sites, which are 
highly cytotoxic and can lead to SSBs if not repaired. DNA bases are estimated to be lost by 
hydrolysis at a rate of 10 000 per cell per day, whereas 95 % of these baseless sites are 
apurinic (Lindahl & Nyberg, 1972; Lindahl, 1993; Kasai et al, 1984). Abasic sites stall DNA 
polymerase and are also highly mutagenic at transcription level, because of the potential of 
RNA polymerase to bypass the lesion by introducing an adenine for the missing nucleotide 
(Dahlmann et al, 2010; Zhou & Doetsch, 1993; Clauson et al, 2010). The amine groups on 
the nucleotides are also exposed to hydrolytic attack which leads to a single base mutation. 
Cytosine, 5-methylcytosine, guanine and adenine are deaminated to uracil, thymine, xanthine 
and hypoxanthine, respectively. DNA is much more prone to deamination when it is in 
single-stranded stages like fork and bubble structures (Lindahl, 1993), suggesting most of the 
deamination to occur during transcription or replication. 
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ROS and oxidative DNA damage 
Oxidative DNA damage results from reaction with reactive oxygen species (ROS). ROS are 
produced from endogenous and exogenous sources and can chemically modify the DNA 
backbone as well as both pyrimidine and purine bases. Oxidative DNA damage includes 
single- and double strand breakage, DNA-protein cross-links, oxidized AP sites, base 
deamination products, oxidized sugar fragments and a plethora of oxidized DNA bases (van 
Loon et al, 2010).  
Cellular metabolism leads to constant generation of ROS as a by-product of oxidative 
phosphorylation in mitochondria. Electrons from organic molecules (from food) are 
transported through the chain of three large protein complexes in the mitochondrial inner 
membrane and delivered to oxygen, leading to formation of H2O  and the cellular energy 
storage adenosine triphosphate (ATP). Most of the oxygen respired is used to achieve the 
electrons in the end of the electron transport chain, some of the oxygen molecules will react 
with electrons before they have completed their journey through the electron transport chain, 
leading to the formation of the superoxide radical (O2•-) (Valko et al, 2007). Superoxide is 
not as reactive itself, but can be converted to the highly reactive hydroxyl radical (•OH). 
Another endogenous source of ROS is peroxisomal metabolism. Peroxisomes are organelles 
present in all eukaryotic cells, involved in the -oxidation of fatty acids. Peroxisome oxidases 
remove hydrogen atoms from fatty acids, by the introduction of oxygen to form hydrogen 
peroxide (H2O2).  H2O2  is further used by the enzyme peroxidase to oxidize other substrates, 
including alcohol, phenols and formic acids present in the cell (Schrader & Fahimi, 
2006;Wanders & Waterham, 2006). This reaction is especially important in the kidneys and 
the liver where peroxisomes detoxify various toxic substances that enter the blood. The 
equilibrium between production and scavenging of ROS in the peroxisomes is a fine balance, 
and disconcert contributes to the total cellular generation of ROS. H2O2 is not as reactive 
itself, but can lead to production of •OH in a process called the Fenton reaction (Wardman & 
Chandeias, 1996). ROS is also formed during the oxidative burst triggered during 
inflammatory responses. During an infection, cells from the immune system will overproduce 
both nitric oxide (NO•) and superoxide (O2•-) which may react to produce peroxynitrite anion 
(ONOO-), an extremely potent oxidizing agent (Ahmad et al, 2009; Burney et al, 1999). 
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Moreover, ROS can arise from exogenous sources. Ionizing radiation and UV-light can 
produce oxygen radicals by hydrolysis of water (Riley, 1994; Black, 1987).  
Cells are equipped with enzymes to disarm free radicals. Catalase and glutathione peroxidase 
catalyze the breakdown of H2O2 and superoxide dismutase catalyzes the destruction of O2•- 
(Salganik, 2001). Although most of the free radicals are neutralized by cellular enzymes,
residual ROS is the major endogenous toxin in the aerobic cell.   
Figure 2. Examples of oxidative base lesions. Cytosine can be oxidized to 5- 
hydroxycytosine (5-OHC) or be deaminated into uracil, which can form the oxidation product 
5-hydroxyuracil (5-OHU). Thymine can be oxidized into thymine glycol (Tg). Guanine can 
form the formamidopyrimidine (FaPy) lesion FaPyG, or it can be oxidized to 8-oxoguanine 
(8-oxoG), which can further form guanidinohydantoin (Gh) or spiroiminodihydantoin (Sp). 
Adenine can be modified to FaPyA. Changes from undamaged nucleotide are marked in red. 
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Up to date, there are identified more than 100 different types of oxidative base lesions in the 
mammalian genome. Some of the most studied lesions are illustrated in figure 2.  The 
pyrimidines cytosine, uracil and thymine can be modified to 5- hydroxycytosine (5-OHC), 5-
hydroxyuracil (5-OHU) and thymine glycol (Tg), respectively. The purines guanine and 
adenine can form the formamidopyrimidine (FaPy) lesions FaPyG and FaPyA. Guanine has a 
low redox potential, which makes it especially vulnerable to oxidation. 7,8-dihydro-8-oxo-
guanine (also known as 8-oxoguanine, 8-oxoG) is formed in large quantities and is the most 
thoroughly examined oxidation product. 8-oxoG is often used as a marker to indicate 
oxidative stress in cells (Klaunig et al, 2011). This lesion is mutagenic due to its ability to 
pair with adenine as well as cytosine leading to a G  T  mutation upon replication 
(Shibutani et al, 1991; Cheng et al, 1992). 8-oxoG has a lower redox potential than guanine 
and is prone for further oxidation, leading to a variety of lesions including the hydantoin 
products guanidinohydantoin (Gh) and spiroiminodihydantoin (Sp) (Duarte et al, 1999; Munk 
et al, 2008).    
Repair mechanisms in mammalian cells  
To counteract all the different types of damage to DNA, the cell has evolved multiple DNA 
repair mechanisms, which can be divided into six major pathways (figure 3): Nucleotide 
excision repair (NER), mismatch repair (MMR), base excision repair (BER), nonhomologous 
end joining (NHEJ), homologous recombination (HR) and direct reversal (DR). 
NER removes a large variety of helix-distorting lesions caused by mutagenic chemicals, 
chemotherapeutic drugs or UV-radiation (Vermeulen, 2011; Hoeijmakers, 2009). More than 
30 proteins are involved in the mammalian NER pathway. NER is divided into two 
subpathways. The global genome NER detects and repairs lesions in the entire genome while 
the transcription coupled NER removes lesions from the transcribed strands of active genes. 
Three genetic disorders are associated with defective NER; xeroderma pigmentosium (XP), 
trichothiodystrophy (TTD), and Cockayne syndrome (CP). All three diseases are associated 
with hypersensitivity to the sun as a consequence of the impaired ability to repair lesions 
caused by UV-radiation. The relative risk for a person with XP to develop skin cancer is 2000 
times higher than for an healthy individual (Diderich et al, 2011; Hoeijmakers, 2009; 
Niedernhofer et al, 2011).  
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Figure 3. Overview of  repair mechanisms in mammalian cells. Nucleotide excision repair 
(NER) repairs bulky DNA lesions like pyrimidine dimers caused by UV-exposure. Mismatch 
repair (MMR) excises and replaces mispaired nucleotides. Base excision repair (BER) 
excises and replaces bases with minor modifications. Nonhomologous end joining (NHEJ) 
and homologous recombination (HR) repairs double strand breaks. Direct reversal (DR) 
repairs alkylated bases. 
The MMR pathway exchanges bases that are mispaired by DNA polymerases and removes 
insertion/deletion loops introduced during replication (Jiricny, 2006). MMR can distinguish 
between the template and the newly synthesized strand and will excise the misincorporated 
nucleotide in a process where 100-1000 nucleotides are removed. Defects in the MMR 
pathway drastically enhances the mutation frequency and can lead to sporadic tumors. Lynch 
syndrome or hereditary nonpolyposis colorectal cancer (HNPCC) is a genetic condition with 
impaired MMR. Nine out of ten HNPCC patients develope cancer during lifespan (Vasen et 
al, 1996).  
The BER pathway is a multistep process repairing small, nonbulky alterations in DNA 
including single base lesions, AP sites and SSBs (Dalhus et al, 2009; Robertson et al, 2009). 
BER is the main pathway for repair of damage caused by ROS and will be described in more 
detail in the next section.   
HR and NHEJ are the pathways for repair of DSBs (Kasparek & Humphrey, 2011; 
Hartlerode & Scully, 2009). HR is the preferred pathway for DSB repair in bacteria and yeast 
and requires an identical DNA copy to complete repair. NHEJ repairs 90 % of the DSBs in 
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mammalian cells and directly ligates the ends of the strand breaks without the need for a 
homologous template. NHEJ is also functioning during development of T- and B-cell 
receptors through V(D)J  recombination. Defects in HR and NHEJ repair can result in 
chromosomal instability leading to somatic mutations. Ataxia telangiectasia (AT) and 
Nijmegen breakage syndrome (NBS) are two genetic human diseases caused by defects in the 
DSB repair. Both diseases are characterized by neuronal degeneration with loss of brain 
function, immunodeficiency and high risk of cancer (Thompson & Schild, 2002).  
DR is a repair mechanism which in contrast to the other repair pathways, only involves one 
enzyme and does not involve cleavage of the DNA backbone or the damaged nucleotide 
(Eker et al, 2009; Drabløs et al, 2004). There are three enzymes performing DR identified in 
mammals. O6-methylguanine-DNA methyltransferase (MGMT/AGT) repairs O6-
methylguanine lesions by the transfer of a methyl group from the lesion to a cysteine group in 
the active site, thereby inactivating itself. MGMT has been shown to be involved in repair of 
alkylating damage caused by several anti-cancer chemotherapeutic drugs (Verbeek et al, 
2008), and MGMT-deficient mice are hypersensitive to this type of treatment (Iwakuma et al, 
1997). Alpha-ketoglutarate-dependent dioxygenase B (AlkB) homologues 2 and 3 (ABH2 
and ABH3) repair 1-methylguanine and 3-methylcytosine by oxidative demethylation (Falnes 
et al, 2007). Photolyases are DR enzymes repairing UV induced pyrimidine dimers in DNA 
by the use of energy from light. Photolyases are found in all kingdoms of life, without 
placental mammals, where pyrimidine dimers are repaired by the NER pathway (Brettel & 
Byrdin, 2010).  
Base excision repair 
The short-patch pathway for BER (SP-BER) requires the function of four proteins as 
demonstrated in figure 4. The pathway is initiated by a DNA-glycosylase that recognizes and 
excises the damaged base by cleavage of the N-glycosylic bond, creating an AP site. The 
DNA glycosylases are divided into two classes, based on their mechanism; they can be 
monofunctional or bifunctional. A monofunctional glycosylase recruits an AP endonuclease 
(APE1) to the abasic site. APE1 creates a nick 5’ to the baseless site. The remaining 5’ –
deoxyribose phosphate (5’dRP) termini is trimmed by the lyase activity of DNA polymerase 
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 (POL ) (Matsumoto & Kim, 1995; Prasad et al, 1998) and the single nucleotide gap is 
filled with the correct base with POL  (Sobol et al, 1996). DNA ligase III (LIG III) bound to 
the non-enzymatic scaffold protein, X-ray repair cross-complementing protein 1 (XRCC1), 
completes the repair process by sealing the nick (Tomkinson & Mackey, 1998; Kubota et al, 
1996; Caldecott et al, 1996; Campalans et al, 2005). However, recent work has demonstrated 
that LIG III is essential for mitochondrial BER but not for nuclear BER, where  DNA ligase 1 
(LIG I) completes repair when LIG III is absent (Gao et al, 2011; Simsek et al, 2011). A 
bifunctional glycosylase has an intrinsic lyase activity. In addition to removal of the damaged 
base, it incises the DNA strand 3’ to the AP site by either -elimination or , –elimination 
(Bailly & Verly, 1987; Bailly et al, 1989). The resulting phospho ,-unsaturated aldehyde 
(PUA) or the phosphate group (P) attached to the 3’ end of the nick are removed by the 
diesterase activity of APE1 or the phosphatase activity of polynucleotide kinase (PNK) 
respectively, to create 3’ OH ends in order to be further processed by POL  and LIG I/LIG 
III (Wiederhold et al, 2004; Chen et al, 1991).  
While the POL  in SP-BER replaces one nucleotide, the DNA polymerases in the long patch 
BER (LP-BER) continues the syntheses until two to 13 nucleotides are reinstated 3’ of the 
lesion (Wallace et al, 2012). Different DNA polymerases (POL , , , , , and 	) are found 
to be involved in strand displacement in different subpathways of LP-BER (Brown et al, 
2011). There is still a lot to be unraveled about the choice and coordination of the different 
DNA polymerases in long patch BER. The flap structure generated by the DNA polymerase 
is removed by flap endonuclease 1 (FEN1) and the nick is sealed by LIG I. Proliferating cell 
nuclear antigen (PCNA) is also involved in long patch BER by interaction with DNA 
polymerases, FEN1 and LIG 1, supporting their functions (Klungland & Lindahl, 1997; 
Matsumoto et al, 1999; Pascucci et al, 1999). The choice between short patch and long patch 
BER seems to be dependent on type of lesion, chemistry of the abasic site, cell cycle stage as 
well as sub nuclear localization of the repair complex (Fortini & Dogliotti, 2007). 
DNA glycosylases 
BER is initiated by a DNA glycosylase, the key enzyme of the BER pathway. At the time 
writing, there are 11 DNA glycosylases identified in mammals. Many of these enzymes have 
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a broad and overlapping substrate range demonstrated by in vitro experiments, and they are 
believed to step in for each another in vivo (Hoeijmakers, 2001; Dalhus et al, 2009; Friedman 
& Stivers, 2010). DNA glycosylases are all monomeric proteins binding non-specific to the 
negatively charged DNA through hydrogen bonds and salt bridges. They move along the 
helix in their search for DNA damage, often only a minor base modification in the vast 
excess of normal DNA. In this searching process, the DNA glycosylase probably switches 
between fast mode, tracking along either one of the DNA grooves or the sugar-phosphate 
backbone, and slow mode where the DNA glycosylase intrudes and distorts the helix, 
creating a wide and flat minor groove (Banerjee et al, 2006; Dunn et al, 2011; Porecha & 
Stivers, 2008; Blainey et al, 2006, 2009). If a lesion is recognized, the DNA glycosylase 
extrudes the damaged nucleotide from the helix by rotating it around the flanking 
phosphodiester bonds. This strategy, known as base-flipping, increases the surface for 
molecular interactions and catalyzes the base release (Friedman & Stivers, 2010; Slupphaug 
et al, 1996; Roberts & Cheng, 1998). A residue from the active site of the enzyme will 
release the damaged base by nucleophilic attack of the anomeric C1’ carbon. 
DNA glycosylases can be classified into structural classes/superfamilies based on their 3D 
structure (Fromme et al, 2004) (Table 1). The uracil DNA glycosylase (UDG) superfamily is 
a group of monofunctional DNA glycosylases. Uracil DNA N-glycosylase (UNG), single-
strand selective monofunctional uracil DNA glycosylase (SMUG1) and thymine DNA 
glycosylase (TDG) are the mammalian enzymes in this class. They are small single domain 
proteins, all recognizing uracil bases in DNA. UNG is well characterized and is highly 
conserved from bacteria to man. SMUG1 can also remove 5-hydroxymethyluracil from 
DNA, while TDG is a mismatch DNA glycosylase and can in addition to uracil recognize 
thymine mismatched to a guanine (Pearl, 2000; Visnes et al, 2009). Methyl-CpG-binding 
domain protein 4 (MBD4) is the other mismatch DNA glycosylase found in mammals, it 
removes uracil and thymine resulting from deamination of CpG and methylated CpG 
respectively (Hendrich et al, 1999). MBD4 is a member of the helix-hairpin-helix (HhH) 
superfamily, which is termed after its distinct conserved motifs (Mullen & Wilson, 1997). 
Mut Y homologue (MUTYH), OGG1 and NTH1 are the other mammalian DNA glycosylases 
with the HhH motif. They are all two-domain proteins with the active site at the junction. The 
damaged nucleotide is displaced by nucleophilic attack from a lysine residue (Dalhus et al, 
2009).  
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Table 1. Mammalian DNA glycosylases 
Superfamilya Protein Reaction 
mechanismb Substrates
c 
UDG 
UNG Monofunctional U, 5-FU 
SMUG1 Monofunctional U, 5OH-meU 
TDG Monofunctional T, U or C opposite G (CpG sites) 
HhH 
MBD4 Monofunctional T or U opposite G at CpG, T opposite O6-meG 
MUTHY Monofunctional A opposite 8-oxoG, 2OHA opposite G 
NTH1 Bifunctional (), 
coupled activities 
Tg, DHU, FaPyG, 5OHU, 5OHC, Sp, Gh 
(dsDNA only) 
OGG1 Bifunctional (), 
uncoupled activities 
8-oxoG opposite C, FaPyG (ds DNA 
only) 
AAG AAG/MPG Monofunctional 3-meA, hypoxanthine, A 
H2TH 
NEIL1 Bifunctional (,) 
coupled activities 
Tg, DHU, DHT, FaPyG, FaPyA, 5OHU, 
5OHC, 8-oxoG,  Sp, Gh 
NEIL2 Bifunctional (,) 
coupled activities 
Overlap with NEIL1 with some minor 
differences 
NEIL3 Bifunctional (), 
uncoupled activities FaPyG, FaPyA, Sp, Gh  
a(Fromme et al, 2004), b(M. L. Hegde, Tapas K Hazra, et al. 2008, Paper II of this thesis), 
c(Barnes & Lindahl, 2004; Morland et al, 2002; Liu et al, 2010; Dou et al, 2003a; Jacobs & 
Schär, 2012; Krishnamurthy et al, 2008; Redrejo-Rodríguez et al, 2011; Zhao et al, 2010; 
Robertson et al, 2009) 
MUTYH is a monofunctional enzyme, and is the only DNA glycosylase that removes 
adenine incorporated opposite 8-oxoG, however this misincorporation can also be repaired by 
enzymes from the MMR pathway (Russo et al, 2007). OGG1 removes oxidized purines and 
is the major DNA glycosylase for removal of 8-oxoG (Bjorâs et al, 1997). NTH1 is highly 
conserved among species and repairs a broad spectrum of oxidized pyrimidines (Dizdaroglu 
et al, 1999). The AAG superfamily only contains one known mammalian DNA glycosylase, 
the alkyladenine DNA glycosylase (AAG/MPG), a single domain enzyme recognizing 
alkylated bases in DNA (Lau et al, 1998). The fourth and last structural class, the helix-two-
turn-helix (H2TH) superfamily, contains three mammalian enzymes; NEIL1, NEIL2 and 
NEIL3 (Prakash et al, 2012).  
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NEIL1, NEIL2 and NEIL3 
The H2TH superfamily had until ten years ago, only known members from the bacterial 
kingdom, termed endonuclease VIII (Nei) and formamidopyrimidine DNA glycosylase (Fpg) 
(Chetsanga & Lindahl, 1979; Melamede et al, 1994; Sugahara et al, 2000). Before then, only 
two mammalian DNA glycosylases repairing oxidative lesions, OGG1 and NTH1, were 
known. However, studies in Ogg1 and Nth1 deficient mice revealed the existence of other 
enzymes repairing oxidative DNA lesions (Klungland et al, 1999; Minowa et al, 2000), 
leading to the search for new DNA glycosylases. The endonuclease VIII-like (NEIL) 
glycosylases NEIL1, NEIL2 and NEIL3 (figure 5) were reported by us and others in 
2002,(Morland et al, 2002; Bandaru et al, 2002; Hazra et al, 2002b, 2002a; Takao et al, 
2002b, 2002a).  
                  
Figure 5. Schematic presentation of mammalian NEIL1, NEIL2, NEIL3 and E. coli Nei 
and Fpg. The first amino acids in the N-terminal, required for catalytic activity and the helix-
two-turn-helix motif (H2TH) are conserved within the superfamily. NEIL1 has a Zn-less 
finger domain and NEIL2, NEIL3, Fpg and Nei have a conserved Zn finger.NEIL3 has an 
additional RAN binding protein (RANbp) Zn finger, a nuclear localization sequence (NLS) 
and a unique structurally disordered C-terminal with two GRF Zn fingers. 
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The highly conserved active site in the H2TH superfamily is found in the first amino acids of 
the N-terminal glycosylase domain (GD). The mammalian NEIL1 and NEIL2, and the 
prokaryote Fpg and Nei contain a Pro2, responsible for the nucleophilic attack of the N-
glycosylic bond of the damage nucleotide. In NEIL3, this residue is replaced by valine 
(Takao et al, 2002b; Morland et al, 2002). In E. coli, Nei mainly excises oxidized 
pyrimidines (Wallace et al, 2003), and  Fpg mainly recognizes oxidized purines and FaPy 
lesions (Tchous et al, 1994). NEIL1 and NEIL2 have been well characterized with respect to 
activity and their preferred substrates are oxidized pyrimidines including the hydantoin 
lesions Sp and Gh, Tg, FaPyA, FaPyG and 5-OHC (Hazra et al, 2002a; Morland et al, 2002; 
Rosenquist et al, 2003; Hailer et al, 2005a) as well as 5-OHU and 8-oxoG in bubble 
structures (Dou et al, 2003b). NEIL1 and NEIL2 recognize most of the same lesions, but with 
minor variations. NEIL3 has overlapping substrate range to NEIL1 and 2, with the main 
substrates being FaPyA, FaPyG and the hydantoin lesions Sp and Gh (Liu et al, 2010). 
In addition to the N-terminal domain responsible for the DNA glycosylase/AP lyase activity 
and the H2TH signature motif of the structural class, all members of this superfamily also 
have a conserved Lysine involved in the catalytic reaction (Zharkov et al, 2003, 2002; 
Doublie et al, 2004). Fpg, Nei, NEIL2 and NEIL3  contain a conserved zinc (Zn) finger, 
while in NEIL1 this domain has been modified to a Zn-less finger domain (Doublie et al, 
2004). Zn fingers are normally found to be involved in interactions to DNA, RNA or other 
proteins. NEIL3 is with its 67 kilodalton (kDa) remarkably larger than the other H2TH 
glycosylases. The C-terminal extension of NEIL3 contains a RAN binding protein (RANbp) -
like Zn finger motif, a nuclear localization signal (NLS) and two additional Zn finger 
domains termed GRF domains after conserved residues in this motif (Bandaru et al, 2002; 
Morland et al, 2002). NEIL1 and NEIL2 are, like NTH1 and OGG1, bifunctional enzymes. 
However, while NTH1 and OGG1 carry out -elimination to produce a single-strand break, 
NEIL1 and 2 possess , -elimination activity (Morland et al, 2002; Hazra et al, 2002b; 
Dizdaroglu et al, 1999; Bjorâs et al, 1997). The catalytic mechanism of NEIL3 will be 
elucidated in the discussion of this thesis. 
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Dispensability and specialization of individual DNA glycosylases 
Knockout (KO) mouse studies reveal that none of the five DNA glycosylases repairing 
oxidative lesions are essential for life (reviewed in Jacobs & Schär 2012). Because a broad 
selection of oxidized lesions is recognized by only five enzymes, the DNA glycosylases have 
a wide substrate range. All known oxidized lesions in DNA are recognized by more than one 
DNA glycosylase in vitro. Examples are FaPyG lesions which are recognized by NEIL1, 
NEIL3, NTH1 and OGG1 (Bjorâs et al, 1997; Luna et al, 2000; Morland et al, 2002; Hazra et 
al, 2002a) and the hydantoin lesions Sp and Gh that are processed by NEIL1-3 and NTH1 
(Hailer et al, 2005a; Liu et al, 2010). The redundancy among the DNA glycosylases reflects 
the importance of efficient repair of oxidative damage, but in addition to compensate for each 
other, the DNA glycosylases tend to have more specialized functions in the organism. NTH1 
and OGG1 are proposed to be the housekeeping DNA glycosylases responsible for global 
BER. They are ubiquitously expressed in most cells and tissues (Imai et al, 1998; Nishioka et 
al, 1999). Also, sequencing of the OGG1 and NTH1 promoter regions show  nonappearances 
of typical TATA or CAAT boxes found in most genes under transcriptional control (Dhénaut 
et al, 2000; Imai et al, 1998). In a comparison study by Odell and coworkers, measurements 
of the cellular concentrations and the specific- and non-specific binding constants reveal that 
NTH1 is much better suited for global recognition and repair than NEIL1 (Odell et al, 2010). 
Moreover, NTH1 and OGG1 only recognize lesions in duplex DNA in contrast to the NEILs 
which seem to prefer single stranded lesions as well as bubble and fork structures, suggesting 
the NEILs to function during replication or transcription. NEIL1 interacts with proliferating 
cell nuclear antigen (PCNA), replication protein A (RPA), FEN1 and Werner’s helicase 
(WRN), all components of the replication fork, indicating a role in replication associated 
repair (Dou et al, 2008; Theriot et al, 2010). NEIL2 is expressed independently of cell cycle, 
it associates to the RNA polymerase II and NEIL2 depleted cells accumulate more DNA 
damage in active than silent genes, suggesting NEIL2 to be involved in repair of transcribed 
genes (Hazra et al, 2002b; Banerjee et al, 2011; Neurauter et al, 2012). While NEIL1 and 
NEIL2 are expressed in most tissues throughout the organism, NEIL3 expression is not as 
prevalent.  
Human NEIL3 is normally found expressed in thymus and testis (Morland et al, 2002). Also, 
elevated expression of NEIL3 in different types of cancers has been reported (Kauffmann et 
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al, 2008; Hildrestrand et al, 2009; Barry et al, 2011). Mouse Neil3 is expressed during 
embryonic development as well as in spleen, bone marrow, testis, thymus and distinct regions 
of brain harboring neural stem cells in adult animals (Torisu et al, 2005; Hildrestrand et al, 
2009; Rolseth et al, 2008; Takao et al, 2009). Also, expression of human NEIL3mRNA is 
upregulated during S-phase of the cell cycle (Neurauter et al, 2012). The expression patterns 
of mNeil3 and hNEIL3 indicate a role for NEIL3 in proliferative tissue.
Neural stem cells  
Stem cells are found in all multicellular organisms. They have the capacity to both self-renew 
and to differentiate into more specialized cells. Embryonic stem cells are derived from the 
inner cell mass of the blastocyst, they are pluripotent and can give rise to all cell types in the 
body. Somatic or adult stem cells are the multipotent stem cells found throughout the 
organism after embryonic development. These stem cells are responsible for replenishment of 
tissue throughout life (Brunt et al, 2012).  
Neural stem cells (NSC) are the multipotent stem cells that can differentiate into the 
components of the central nervous system (CNS). NSCs can make commitments to 
neurogenesis and become functional neurons, or they can enter gliogenesis. Glia cells are the 
non-neural cells that support and protect the neurons. There are several types of glia cells 
present in the brain, among them are microglia, astrocytes and oligodendrocytes (figure 6). 
The neurons form networks and transmit information through chemical and electrical 
signaling. Neurogenesis is mainly happening during embryonic development and most of the 
neurons are as old as their host (Martino et al, 2011; Zhao et al, 2008). However, some 
neurogenesis continues in distinct parts of the adult brain: the subgranular zone (SGZ) of the 
hippocampus and the sub-ventricular zone (SVZ) of the lateral ventricles. Neurons 
differentiated in the SGZ migrate into the granule cell layer of dentate gyrus (DG) and 
become dentate granule cells. Neurons differentiated in the SVZ migrate through the rostral 
migratory stream to the olfactory bulb (Zhao et al, 2008; Spitzer, 2006). 
20 % of the glia cells in the brain are microglia (Lawson et al, 1992), the macrophages of the 
CNS. The CNS has been considered an immune-privileged organ, lacking a lymphatic system 
and separated from the circulatory system by layers of endothelial cells known as the blood-
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brain-barrier. Microglia protects the sensitive neural tissue from intruders through this barrier 
by phagocytosis (Yang et al, 2010; Tremblay et al, 2011). Astrocytes are the most abundant 
cell type of the human brain. These star shaped cells support the neurons physically through 
their structuring of the brain and biochemically through their provision of nutrients and ions. 
Upon brain injury, astrocytes play an important role in the repair and scaring process of the 
damaged tissue (Freeman, 2010; Sofroniew & Vinters, 2010). Oligodendrocytes coat and 
protect axons of the nerve cells with myelin sheets. The myelin is formed from the cell 
membrane and provides insulation to the axon, which increases the speed of the electrical 
impulses. A single oligodendrocyte can coat the axons of several nerve cells (Nave, 2010). 
            
Figure 6. Cells of the brain. In the brain, neural stem cells (NSC) can self-renew or 
differentiate into neuronal linage, becoming functional neurons, or into a glial linage. 
Astrocytes, oligodendrocytes and microglia are all glial cells. NPC, neural progenitor cell; 
GPC, glial progenitor cell.  
In adult humans, the brain consists of 2 % of the total body weight, but it consumes 10 % of 
the carbohydrates and almost half of the oxygen respired (Magistretti & Pellerin, 1996). The 
need for oxygen is high due to the vast amount of ATP used to maintain neuronal signaling. 
The high metabolic activity, low levels of antioxidant enzymes, high amounts of iron and the 
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formation of ROS during synthesis of neurotransmitters make the brain more prone to 
oxidative attack than other organs (Halliwell, 2006).  The brain, as well as most other organs 
of the body consists of a diversity of cells with different needs regarding genome 
maintenance. NSCs are the most versatile cells of the brain and are put on high pressure to 
maintain genomic integrity (Rocha et al, 2012). A lesion in NSCs can, if left unrepaired, be 
fixated through replication, leading to mutations in a whole glial or neuronal linage. In 
terminally differentiated cells, like neurons, a certain degree of mutations are acceptable in 
the non-transcribed regions of the genome and global DNA repair is less active while the 
transcribed genes are repaired more efficient (Banerjee et al, 2011; Nouspikel, 2007; 
Nouspikel & Hanawalt, 2000, 2002). However, in contrast to most other post mitotic cells in 
the body, neurons are lasting throughout life. 
Involvement of BER in aging and diseases 
Accumulations of DNA damage are detected in several human pathologies including cancers, 
immunological dysfunctions and neurodegenerative diseases (Olinski et al, 2002; Hegde et 
al, 2012; Klaunig et al, 2011; Halliwell, 2006; Bohr et al, 2007). Defects in a DNA repair 
enzyme can be directly correlated to development of a disease, as previously outlined. 
However, the functions of the various BER glycosylases in disease prevention and 
progression are complex and there is little evidence about defects causing diseases. 
Mouse models 
Transgenic mouse models have been developed to unravel the function of the different BER 
components. Except Tdg-deficiency, that is embryonic lethal (Cortázar et al, 2011), mice 
deficient in one of the other DNA glycosylases display normal development and lack of an 
obvious phenotype. However, deeper investigations of the different mouse models are giving 
us interesting information about the role of the different DNA glycosylases in modulating 
disease risk. In contrast to the mild phenotypes of the DNA glycosylase deficient mice, the 
downstream BER enzymes Ape1, Pol , Lig III and Xrcc1 are all lethal (Ludwig et al, 1998; 
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Sugo et al, 2000; Puebla-Osorio et al, 2006; Tebbs et al, 1999). Following is a summary of 
what is known about mice lacking oxidative DNA glycosylases. 
Ogg1-deficient mice accumulate oxidative 8-oxoG lesions followed by elevated mutation 
frequency in liver (Klungland et al, 1999; Minowa et al, 2000). Aged mice lacking Ogg1 
exhibit spontaneous motor behavior deficiency as well as neurochemical and histological 
changes in the brain (Cardozo-pelaez et al, 2012). Mutyh-deficient mice do also accumulate 
8-oxoG in liver, but display no overt phenotype. However, Ogg1-/-/Mutyh-/-  mice is 
predisposed for developing lymphoma and tumors in lungs, ovaries, and small intestines 
(Russo et al, 2004; Xie et al, 2004). Nth1-deficient mice accumulates FaPyA in kidney and 
liver (Chan et al, 2009). Moreover, Nth1-/-/Ogg1-/-  mice showed impaired repair capacity of 
5-OHC and 5-OHU in mitochondria (Karahalil et al, 2003). Neil1-deficient mice accumulate 
FaPyA and FaPyG lesions in brain, kidney and liver (Chan et al, 2009), and they exhibit a 
high chance of developing obesity followed by symptoms similar to human metabolic 
syndrome (Vartanian et al, 2006). The increased susceptibility to overweight is suggested to 
be caused by the low tolerance to oxidative stress (Sampath et al, 2011). It is worth 
mentioning that also Ogg1-deficient mice were a bit larger compared to their wild-type 
littermates (Arai et al, 2006). Nth1-/-/Neil1-/- mice showed a higher incidence of tumors on 
lungs and liver (Chan et al, 2009). There are so far no reports about the consequence of Neil2 
deficit, but we are breeding them in the lab and they are viable and fertile (personal 
communication with Gunn Hildrestrand). The Neil3-deficient mouse model was published 
some years ago, where no phenotype was detected (Torisu et al, 2005). Characterization of 
the Neil3-deficient mouse model is included in this thesis and will be discussed later. 
Polymorphism and disease 
Single nucleotide polymorphisms (SNPs) of DNA glycosylases may affect BER efficiency. A 
third of the human population has the OGG1 SNP variant Ser326Cys. Biochemical analysis 
of OGG1Ser326Cys reveals a decrease in glycosylase activity (Audebert et al, 2000; 
Sidorenko et al, 2009). A large number of studies have investigated whether this 
polymorphism leads to predisposition for different cancers, where most studies find none or 
marginally correlation with disease (Weiss et al, 2005; Li et al, 2008). Patients with biallelic 
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deficiency in the MUTYH gene have higher susceptibility to develop MUTYH-associated 
polyposis (MAP) a common type of colorectal cancer (Al-Tassan et al, 2002; Jones et al, 
2002; Jasperson et al, 2010). MAP has also been found to be associated with tumors on 
breasts, ovarian, bladder and skin (Vogt et al, 2009). No convincing correlation between 
variants of the NEIL enzymes and disease has been found. SNPs of the NEILs have been 
reported in cancer patients, but most of these variants are only found in a small group of 
patients (usually one to two), or they have also been found in healthy individuals (Dallosso et 
al, 2008; Forsbring et al, 2009). An example is the NEIL2 variants Arg103Gln and 
Arg257Leu, each found in a patient with family history of gastric cancer, and not in the 
control group in one study (Broderick et al, 2006). Another study identifies the same variants 
in both cancer patients and in the control group (Dallosso et al, 2008). There are no reports of 
NTH1 variants associated with disease. 
Aging and neurodegeneration 
The ‘oxidative stress theory of aging’ suggests that accumulation of oxidative lesions in the 
genome during the life span of an organism results in a gradual decline of cellular functions 
which eventually leads to death (Harman, 1981). The risk for developing a neurodegenerative 
disease increases with age. Accumulations of oxidative damage are detected in various 
neurodegenerative conditions like Parkinson`s disease (PD), Alzheimer`s disease (AD), 
Huntington`s disease (HD) and amyotrophic lateral sclerosis (ALS). There is growing 
evidence supporting the fact that BER is involved in maintenance and protection of neuronal 
tissue, but no clear correlation between BER deficiency and neurodegenerative diseases has 
been demonstrated (Hegde et al, 2012; Halliwell, 2006; Coppedè & Migliore, 2009).  
Several reports suggest that OGG1 functions in protecting neurons against 
neurodegeneration. The OGG1 polymorphic variant Ser326Cys has been found to be weekly 
associated with ALS and HD, but not with AD and HD (Coppedè & Migliore, 2009; Coppedè 
et al, 2010, 2007a, 2007b). Another study finds that four out of 14 AD patients had OGG1 
variations, two single base deletions resulting in abolished OGG1 activity, and two single 
base substitutions resulting in reduced OGG1 activity, while none variations were detected in 
the control group (Mao et al, 2007). Ischemic stroke is a neurodegenerative event caused by 
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blocked blood supply to parts of the brain. The oxygen deprivation leads to mitochondria 
dysfunction and overproduction of ROS, immediately followed by extensive oxidative DNA 
damage (Saeed et al, 2007; Vieira et al, 2011). Stroke induces expression of several BER 
enzymes, including Ogg1, Neil1, Ung, Xrcc1, Pol, Ape1 and LigIII in mice and rats (Lan et 
al, 2003; Li et al, 2011; Canugovi et al, 2012; Endres et al, 2004; Liu et al, 2011). Hypoxia-
ischemia (HI) is a method mimicking stroke in animal models. Transgenic mice, deficient in 
Neil1, Ung or Ogg1 do all get larger brain damage after HI compared to wild-type mice, 
demonstrating an important role for these glycosylases in repair of stress induced damage 
(Canugovi et al, 2012; Liu et al, 2011; Endres et al, 2004). The DNA glycosylases Neil1, 
Neil2, Nth1 and Ogg1 are expressed in neuronal tissue in mouse brain throughout 
development and adulthood (Rolseth et al, 2008), while Neil3 is only found during 
development as well as in SVZ and DG, the distinct areas of the adult brain harboring NSCs 
(Hildrestrand et al, 2009). These findings suggest a role of Neil3 in maintenance of NSCs. 
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Aims of the study 
DNA is continuously modified by ROS from the cellular environment (Hegde et al, 2012). 
BER is the major pathway for repair of ROS induced damage, and is triggered by the action 
of a DNA glycosylase, which recognizes and excises the damaged nucleotide (Dalhus et al, 
2009). There are three homologues of endonuclease VIII-like (NEIL) DNA glycosylases in 
mammalian cells; NEIL1, NEIL2 and NEIL3. At the time this project was initiated, little was 
known about NEIL3.We hypothesized that NEIL3 was a functional DNA glycosylase, 
recognizing oxidative lesions in DNA. The aim of the first part of the study was to 
characterize the biochemical properties of recombinant human NEIL3. To address this, we 
cloned Neil3 into a suitable expression vector and developed a purification strategy for the 
human NEIL3 protein (paper I). Further, we performed site-directed mutagenesis and 
characterized substrate specificity and reaction mechanism by in vitro excision/incision 
assays of wild-type and mutant enzymes to pinpoint residues involved in catalysis (paper II). 
These experiments would give us knowledge about the catalytic properties of the 
recombinant enzyme, which makes the fundament for further research on NEIL3. 
The most prominent expression of mouse Neil3 is found in the developing brain and in 
compartments of the adult brain harboring NSCs (Hildrestrand et al, 2009) as well as in 
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proliferative lymphatic tissue (Torisu et al, 2005). The Neil3 knockout mice are viable and 
fertile, lacking an overt phenotype (Torisu et al, 2005). Recombinant mouse Neil3 is found to 
recognize and repair the hydantoin lesions Sp and Gh, with preference for lesions in ssDNA 
(Liu et al, 2010). Sp and Gh have a high mutagenic potential and are strong replication blocks 
in vivo (Henderson et al, 2003). We hypothesize that Neil3, by the removal of hydantoin 
lesions from DNA, has a role in maintaining genome integrity and thus promoting 
proliferation of neural and lymphatic tissue. The aim of the second part of this thesis was to 
establish the role of Neil3 in proliferative tissues. To address this, we developed a Neil3-
deficient mouse model and investigated brain structure and repair activity of different tissues 
in comparison to Neil3-proficient mice (paper III). Further, we exposed wild-type and Neil3-
deficient mice to hypoxia-ischemia (HI), a method known to induce extensive DNA damage 
and apoptosis in brain, followed by tissue regeneration (paper IV). These studies would give 
us knowledge about the biological role of Neil3 in maintaining genome integrity of stem 
cells. 
Summary of results 
Paper I: Expression and purification of NEIL3, a human DNA glycosylase homolog. 
NEIL3 shares high sequence similarities to NEIL1 and NEIL2, but has a long C-terminal 
extension with a unique GRF Zn-finger domain. The biochemical properties of NEIL3 were, 
at the time-point of this study, not elucidated. Here, we present a protocol for successful 
expression and purification of a truncated human NEIL3 (amino acids 1-301) that contain the 
complete E. coli Fpg/Nei-like glycosylase domain (GD) but lack the C-terminal. The full-
length (FL) NEIL3 was also expressed in this study, but we were only able to partially purify 
it. Bioinformatics analysis of NEIL3 predicts that a ~100 residues segment, between the GD 
and the GRF Zn-finger is disordered.Disordered regions in proteins do usually not have a 
tertiary structure and often lead to difficulties in protein expression, purification and 
crystallization. Removal of the disordered segment resulted in successful expression and 
purification of GD NEIL3. However, we did not detect any glycosylase activity on the 
substrates tested. We suggest that the disordered segment of NEIL3 requires specific 
conditions only found in the eukaryotic cell, like posttranslational modifications (PTMs) or 
chaperones, to obtain correct tertiary structure.  
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Paper II: Human NEIL3 is mainly a monofunctional DNA glycosylase with affinity to 
spiroiminodihydantoin and guanidinohydantoin.
The main substrates of NEIL3 have been reported to be the hydantoins Sp and Gh, Tg and 
FaPy lesions (Liu et al, 2010, 2012). In this work, we have purified the core glycosylase 
domain (GD) of human NEIL3 and elucidated the catalytic mechanisms. GD NEIL3 removed 
the hydantoin lesions Sp and Gh in single- and double-stranded DNA as well as 5-OHC and 
5-OHU lesions in ssDNA. In contrast to the concerted catalytic mechanisms of NEIL1 and 
NEIL2, the DNA glycosylase/AP lyase activities of NEIL3 were demonstrated to be non-
concerted, where base release was more efficient than strand incision. Fpg/Nei and NEIL1/2 
contain a catalytic Pro2, while this amino acid is replaced by Val in NEIL3. Biochemical 
mapping of the catalytic N-terminus of NEIL3, by site-directed mutagenesis, demonstrated 
that Val2 is the residue responsible for the non-concerted action of NEIL3. Furthermore, 
Lys81 is found to be the catalytic residue, essential for DNA glycosylase activity. We suggest 
that the substitution of the second amino acid from proline to valine has directed NEIL3 to 
act as a monofunctional glycosylase in vivo. 
Paper III: Loss of Neil3, the major DNA glycosylase activity for removal of hydantoins 
in single-stranded DNA, reduces cellular proliferation and sensitizes cells to genotoxic 
stress. 
Neil3 is expressed in brain during embryonic development. We analyzed and compared brain 
structure of newborn wild-type and Neil3-deficient mice by immunoreactivity, but did not 
find any differences regarding brain architecture or distribution of neural and glial tissue. 
However, in vitro culturing of neuronal stem/progenitor cells revealed that Neil3-deficient 
cells had unaffected differentiation capacity, but impaired ability to self-renew. Proliferation 
was also reduced in mouse embryonic fibroblasts (MEFs) derived from Neil3-deficient 
embryos and these cells were sensitive to both the oxidative agent paraquat and interstrand 
cross-link inducing agent cisplatin. Total cell extract of brain, heart, thymus and spleen from 
Neil3-deficient mice displayed reduced repair activity against Sp and Gh lesion in ssDNA, 
assayed by excision/incision assays. Our data suggests that Neil3 is involved in repair of 
hydantoin lesions in proliferative tissue. 
PRESENT INVESTIGATION 




Paper IV: Endonuclease VIII-like 3 (Neil3) DNA glycosylase promotes neurogenesis 
induced by hypoxia-ischemia. 
To address our hypothesis that Neil3 is involved in DNA repair of NSPCs, we exposed wild-
type and Neil3-deficient mice to oxidative stress by HI. HI resulted in major tissue damage in 
the forebrain. We did not detect differences in neuronal death between wild-type and Neil3-
deficient animals three to ten days after HI. However, six weeks after injury, the Neil3-
deficient mice demonstrated impaired recovery of brain tissue by reduced volume of neuronal 
tissue. Supporting these results, Neil3-deficient animals showed a reduction in proliferating 
NSPCs migrating to the striatum three to ten days after HI, compared to wild-type. Neil3-
deficient animals also showed a decreased microglial response to HI. In vitro cultured NSPCs 
(neurosphere culture), isolated from wild-type animals after HI, showed a high proliferative 
response which was absent in the Neil3-deficient cells. Also, the differentiation pattern of the 
Neil3-deficient neurospheres was altered with fewer cells entering neuronal linage. Further, 
the Neil3-deficient cells exhibited increased accumulation of strand breaks compared to wild-
type cells. Neil3-deficient neurospheres had impaired repair activity towards Sp and Gh 
lesions in ssDNA as measured by excision/incision assay of total cell extract. Our data 
supports a role for Neil3 in promoting proliferation of NSPCs by removal of the replication 
blocks; Sp and Gh. 
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Structural properties of NEIL3 
After the discovery of the base excision mechanism, BER was believed to be one of the 
simpler repair pathways in the cell, involving four to five enzymes only (Dianov & Lindahl, 
1994). But along with new evidence, it is getting clearer that BER is highly complex, 
involving a network of extensively regulated sub-pathways, involving more accessory 
proteins, transcription factors and posttranslational modifications (PTMs) than first assumed 
(Sampath et al, 2012; Jacobs & Schär, 2012; Odell et al, 2012; Wallace et al, 2012). Paper I 
and II are studies on the structural properties of NEIL3 and here I discuss my findings in 
accordance to its presumed functions in BER. 
Reaction mechanism  
Along with the discovery of the NEIL enzymes in 2002, a new sub-pathway of BER was 
identified. The DNA glycosylases specific for oxidative base lesions are all bifunctional with 
intrinsic AP lyase activity. OGG1 and NTH1 catalyze -elimination, generating 3’PUA 
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which is further processed by APE1, while NEIL1 and NEIL2 perform ,-elimination 
resulting in 3’P which is processed by PNK (Wiederhold et al, 2004). Involvement of PNK in 
repair of oxidative damage has been suggested before, however the direct role of PNK in 
BER was not clear before the discovery of the NEILs (Karimi-Busheri et al, 1999; Yang et 
al, 1996; Rasouli-Nia et al, 2004). It is now believed that NEIL1/NEIL2 together with PNK 
act in an APE1 independent subpathway of BER (Wiederhold et al, 2004). Interestingly, in 
contrast to the other NEIL enzymes, NEIL3has uncoupled excision/incision activities where 
base excision is more efficient than strand incision. Further, NEIL3 incise the damaged strand 
mainly by -elimination, although some of the abasic DNA is processed by ,-elimination 
(paper II, Liu et al. 2010). In paper II we show that substituting Val2 in NEIL3 to Pro, the 
catalytic nucleophile in NEIL1 and NEIL2, results in an enzyme with concerted DNA 
glycosylase/AP lyase mechanism performed by ,-elimination. 
These data indicates that Val2 is the residue responsible for the monofunctional reaction 
mode of NEIL3. Moreover, a NEIL2 homologue found in mimivirus (mvNeil2) also contains 
a valine as the second amino acid and incises DNA by a mix of - and ,-elimination 
(Bandaru et al, 2007).  Further, studies on Fpg/Nei enzymes have shown that substitution of 
Pro2 affects the reaction mechanism, supporting our results (Saparbaev et al, 2002; Burgess 
et al, 2002; Zharkov et al, 1997; Vik et al, 2012).  
Uncoupled glycosylase and AP lyase activities have also been shown for mammalian OGG1 
and NTH1 (Morland et al, 2005; Marenstein et al, 2001). This suggests that the intrinsic AP 
lyase activity of the DNA glycosylases plays a more prominent role in the PNK dependent 
than the APE1 dependent subpathway of BER. APE1 has a remarkably higher catalytic 
turnover rate on AP sites than NEIL3 (Strauss et al, 1997) and we suggest that the AP lyase 
activity of NEIL3 is not of biological significance in mammalian BER. The E. coli enzymes 
Fpg,  Nth and Nei  have tightly coupled glycosylase/AP lyase activities, catalyzing strand 
incision at about the same rate as base release (Krokan et al, 1997; Kow & Wallace, 1987). 
The dominant monofunctional reaction mode of NEIL3 indicates evolutionary 
pressure/adaptation to avoid strand incision coupled to the base excision reaction, supporting 
that NEIL3 recruits APE1 to perform the incision reaction at the abasic site. NTH1 and 
OGG1 are reported to repair oxidative lesions in duplex DNA only, while NEIL1, NEIL2 and 
NEIL3 also recognize and repair lesions in single-stranded DNA (Paper II, Hong Dou et al. 
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2003; D O Zharkov et al. 2000). Therefore, NEIL3 appears to be the only DNA glycosylase 
removing hydantoin- and FaPy lesions in ssDNA without generating a strand break.  
Another feature unique for NEIL3 is a 30 residue insert found in the glycosylase domain of 
the protein (paper II). This loop is positioned close to the lesion recognition pocket, it is not 
conserved and varies in length and sequence among species. The function is unknown and we 
speculate that it is involved in regulating the enzyme by blocking/promoting DNA 
glycosylase activity. 
Benefits of a disordered C-terminal 
Disordered protein segments do not form a stable tertiary structure in vitro. Most of the 
mammalian DNA glycosylases contain a protein sequence, 50-100 amino acids in size, with a 
high degree of disorder. OGG1 is among the exceptions and have shorter (about 10 residues) 
disordered fragments in both ends. NEIL1 contains a 100 amino acid long disordered 
sequence in the C-terminus, NEIL2 contains an internal disordered segment at the residues 
45-130 and NEIL3 contains a disordered region of proximately 100 residues in the C-
terminal prior to the GRF Zn finger (Paper I, Hegde et al, 2010). In contrast, disordered 
regions are absent in the E.coli Nei homologue (Hegde et al, 2010). Interestingly, removal of 
56 C-terminal residues of human NEIL1 leads to a fourfold increase in glycosylase activity 
(Doublie et al, 2004). Similarly, human NTH1 has an N-terminal extension lacking in E.coli
Nth, and truncation of these residues leads to increased activity (Liu & Roy, 2002). In 
agreement with these results, we find that full-length NEIL3 has weaker glycosylase activity 
on Sp and Gh lesions in single- and double-stranded DNA than NEIL3 with the C-terminal 
truncation (GD NEIL3) (unpublished data). In partial agreement with our unpublished results, 
Liu and coworkers demonstrates that recombinant mouse Neil3 get enhanced activity against 
hydantoin lesions in dsDNA but not ssDNA by truncation of the disordered C-terminal 
segment (Liu et al, 2010). We propose that the disordered segment of NEIL3 regulates the 
enzymatic activity, by inhibiting activity in the absence of downstream BER components. 
The presence of non-conserved, disordered regions in all DNA glycosylases repairing 
oxidative lesions, suggests that these segments have important functions like DNA and 
protein interactions, damage recognition or protein regulation. 
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DNA glycosylases search for base lesions by a combination of sliding along the helix and 
intersegmental transfer (Friedman & Stivers, 2010; Odell et al, 2012).  Proteins with the 
H2TH DNA binding domain (homeodomain proteins) are reported to have increased number 
of contact points to DNA through disordered segments (Tóth-Petróczy et al, 2009) and they 
are suggested to efficiently jump from one DNA molecule to another through an 
intermediate, where the recognition pocket of the protein is interacting with one DNA 
fragment and the disordered tail is interacting with a second (Vuzman et al, 2010). Tóth-
Petróczy and coworkers also claim that homeodomain proteins fold correctly only when their 
disordered tails are in contact with DNA. 
It is established that the proportion of disordered proteins correlates with the complexity of an 
organism (Ward et al, 2004). Genome wide analysis have also shown that proteins that 
interact with many partners are more likely to have disordered sections than proteins with few 
partners (Haynes et al, 2006). NEIL1 forms complexes with the downstream BER proteins 
FEN1, POL , LIG III, XRCC1 and PCNA through interactions with the 100 residues long 
disordered C-terminal (Hegde et al, 2008b; Wiederhold et al, 2004; Dou et al, 2008). NEIL3 
is found to co-localize with replication protein A (RPA) (Morland et al, 2002). Further, pull-
down experiments with recombinant NEIL3 C-terminal in fusion with a GST tag in cell 
extract indicate interaction withpoly[ADP-ribose] polymerase 1 ( PARP1), Ku70, DNA 
protein kinase (DNA-PK) and RPA (own unpublished results). PARP1 is known to be 
involved in single-strand break repair. PARP1, Ku70 and DNA-PK are central proteins 
involved in double-strand break repair, while RPA binds single-stranded DNA during repair 
and replication. RPA is also involved in homolog recombination and telomere maintenance 
(Wang et al, 2012; Muller et al, 2005; Pawelczak et al, 2011; Sakaguchi et al, 2009). NEIL3, 
with the long disordered C-terminal, is likely to interact with several other proteins.  
PTMs of proteins play important roles in many cellular processes including DNA repair. 
PTMs on DNA glycosylases may regulate substrate binding, subcellular localization and 
protein-protein interactions (Fan & Wilson, 2005). Acetylation of Lys49, in the disordered 
region of NEIL2, is a switch which inactivates the DNA glycosylase/AP lyase activity 
(Bhakat et al, 2004). Acetylation of Lys338 and Lys341 in the short disordered C-terminal of 
OGG1 increases the turnover for 8-oxoG lesions by reducing the affinity for AP sites (Bhakat 
et al, 2006). There is a lot to be unraveled about PTMs on NEIL3. A single modification can 
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be essential for proper repair activity, but also for correct folding (Tokmakov et al, 2012).  
Types and positions for modifications can vary in between eukaryotic and prokaryotic cells 
(Soppa, 2010). In paper I and II, active fractions of GD NEIL3 without the disordered C-
terminal were easily purified from E. coli, while FL NEIL3 tended to form aggregates and 
displayed irregular migration during separation on a denaturing gel. On the contrary, by 
expression in a mammalian system with rabbit reticulocyte lysate, FL NEIL3 migrated as 
predicted by size (paper I). The lack of correct PTMs of FL NEIL3 expressed in E. coli is one 
possible explanation for the aberrant tertiary structure. 
A unique role for Neil3 in proliferative tissue 
We generated a mouse model deficient in the Neil3 gene by engineered depletion of exon 3-5 
to unravel the in vivo functions of Neil3 (paper III and IV). In accordance with a previous 
report (Torisu et al, 2005), our Neil3-deficient mice were healthy and fertile with no 
profound phenotype. 
Neil3 in neural stem cells 
In paper IV, we exposed perinatal mice to hypoxia and ischemia (HI), a well-known method 
mimicking hypoxic-ischemic encephalopathy, a type of stroke, in the perinatal brain. HI 
resulted in major brain damage, with no differences in infarct size, between Neil3-proficent 
and Neil3-deficient mice, when analyzed three to ten days after injury. However, six weeks 
after injury, Neil3-deficient mice demonstrated impaired recovery of brain tissue, suggesting 
a role for Neil3 in neuronal stem/progenitor cells (NSPCs) rather than post mitotic brain 
tissue.  
NSPCs are limited in number in mouse brain, and had to be propagated in vitro for further 
analysis. There is currently no method for homogenous culturing of neural stem cells. Cells 
from the SVZ form floating sphere-like structures, neurospheres, when propagated in the 
right conditions (Ahmed, 2009; Arvidsson et al, 2002; Jensen & Parmar, 2006; Reynolds & 
Weiss, 1992). Neurospheres consists of a mix of stem cells, progenitor cells and terminally 
differentiated cells, where the ability to form new neurospheres (colony forming unit, CFU) 
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in the next passage is correlated with the amount of stem cells in the population (Reynolds & 
Weiss, 1992). As demonstrated in paper III and IV, neurospheres from the Neil3-deficient 
mouse showed reduced proliferative capacity. Moreover, the differentiation pattern of the 
Neil3-deficient neurospheres, isolated after HI, was altered with less cells entering neuronal 
linage (paper IV). These results are in partly agreement with another report where 
knockdown of Neil3 resulted in decreased proliferation, gliogenesis and neurogenesis of 
NSPCs isolated from the embryonic rat brain (Reis & Hermanson, 2012). Neil3-deficient 
neurospheres accumulated DSBs after exposure to paraquat, while we did not find a 
difference between the two genotypes in accumulation of DSBs in the ischemic brain tissue. 
In addition, we demonstrate that wild-type, but not Neil3-deficient neurospheres were able to 
repair Sp and Gh lesions from ssDNA (paper IV), while the repair activity against these 
lesions were almost undetectable in whole-brain extract from both genotypes (paper III). 
Altogether, our results suggest that Neil3 does not function in the terminally differentiated 
cells of the brain, but have a prominent role in NSPCs. Ten days after injury, we detected a 
decreased number of proliferating NSPCs migrating from SVZ to repopulate the striatum in 
Neil3-deficient mice, compared to wild-type mice. The pool of quiescent NSPCs in SVZ was 
not affected by Neil3-deficiency, suggesting Neil3 to have a role in proliferative, but not 
quiescent NSPCs. Other groups have performed transient middle cerebral artery occlusion on 
adult mice deficient in Neil1, Ogg1 and Ung, and in contrast to our Neil3-deficient model 
these mice showed increased tissue damage due to impaired repair of stress induced DNA 
damage in postmitotic brain tissue (Liu et al, 2011; Endres et al, 2004; Canugovi et al, 2012). 
Oxygen is normally tightly controlled within the brain (Simon & Keith, 2008; Vieira et al, 
2011). Various reports have listed oxygen concentrations in rodent brain to range from 0.1-5 
% depending on the specific regions (Seyde & Longnecker, 1986; Sick et al, 1982). Oxygen 
is known to be involved in control of cellular fate of NSPCs. Low level of oxygen in the 
embryonic brain stimulates hypoxia-inducible factor 1 (HIF-1) which promotes 
proliferation and is essential for early brain development and neurogenesis (Iyer et al, 1998). 
Increasing oxygen tension degrades HIF-1 which promotes differentiation (Mazumdar et al, 
2010). When NSPCs are dissected out from their natural niche and grown in vitro in ambient 
air (21 % oxygen) in an incubator, they are exposed to non-physiological levels of oxygen. 
NSPCs derived from Neil3-deficient mice display impaired proliferation while we do not find 
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any aberrations in the cellular composition of the brain of newborn KO animals. The 
disagreement in data may be due to the hyperoxic conditions in vitro. 
A high level of ROS induced damage is, as outlined previously, associated with 
neurodegenerative diseases and aging (Hegde et al, 2012; Halliwell, 2006; Jeppesen et al, 
2011). Interestingly, reactive oxygen is not always a cellular threat. There is an emerging 
understanding of ROS functioning as messenger molecules in redox signaling pathways 
controlling cellular physiology including apoptosis, proliferation and differentiation of 
embryonic and somatic stem cells (Nitti et al, 2010; Varum et al, 2009; Sauer et al, 2000; Le 
Belle et al, 2011; Tsatmali et al, 2006). Elevated levels of ROS are associated with stem cell 
differentiation through activation of the p38 mitogen-activated protein kinase (p38 MAPK) 
(Cho et al, 2006; Ito et al, 2006; Le Belle et al, 2011). Moreover, research on naïve 
neurospheres has demonstrated that stress-induced accumulation of mitochondrial DNA 
damage leads to a shift in the differentiation of NSCs toward astrocytic linage (Wang et al, 
2011, 2010). These studies underscore the importance of DNA glycosylases to promote 
correct proliferation and differentiation of NSPCs.
Recently, we published a report about impaired neurogenesis of aged Neil3 knockout mice, 
and consequences for learning and memory (Regnell et al, 2012). Behavioral studies revealed 
that Neil3-deficient mice have learning and memory deficits and a reduced anxiety-like 
behavior. Similar to the results from paper IV, NSPC from aged Neil3 knockout mice showed 
impaired proliferative capacity and reduced repair of hydantoins in ssDNA. In addition, we 
here demonstrated that aged Neil3-deficient mice have aberrant distribution of excitatory and 
inhibitory receptor subunits and altered synapse composition within hippocampus. It appears 
that Neil3 is required for maintenance of adult neurogenesis to counteract the age-associated 
reduction of cognitive performance.  
Neil3 in lymphatic organs 
Mouse Neil3 mRNA is expressed in thymus and spleen, and repair of hydantoin lesions in 
ssDNA is impaired in Neil3-deficient extracts from these organs (paper III), suggesting a 
functional role for Neil3 in hematopoietic/lymphoid organs. In support of this hypothesis, 
mouse Neil3 has previously been reported to be expressed in bone marrow and several B-cell 
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lines, and expression is induced by mitogen stimulation where splenocytes starts to 
proliferate (Torisu et al, 2005).  The Neil3-deficient animals generated by Torisu and 
coworkers also exhibited a tendency of reduction of peripheral white blood cell number. AP 
endonuclease 2 (Ape2) shares several features with Neil3 and there are several reports on the 
mammalian Ape2 and its function in lymphoid tissue (Ide et al, 2004; Sabouri et al, 2009; 
Guikema et al, 2011). Ape2 and Neil3 are structurally related, both contain a long stretch of 
disordered structure and a duplicate of the GRF Zn-finger at the C-terminal. The GRF Zn-
finger is a unique motif, only found in a very few other mammalian proteins, suggesting 
Neil3 and Ape2 to be involved in the same pathway where they share common interaction 
partners. Further, they both have reduced AP lyase functions compared to their homologues 
Neil1/2 and Ape1 (paper II, Hadi & Wilson, 2000; M Takao et al., 2009). Both proteins have 
induced expression in S-phase, Neil3 has a putative PCNA binding motif and Ape2 has been 
shown to associate with PCNA, linking their activities to replication (Neurauter et al, 2012; 
Morland et al, 2002; Burkovics et al, 2009; Ide et al, 2004). Ape2 is found to be necessary 
for normal cell cycle progression in proliferating B cells and plays an important role in 
recovery of lymphoid tissue cells after chemotherapeutic depletion of the bone marrow 
(Guikema et al, 2011; Ide et al, 2004). Based on our knowledge about the importance of 
Neil3 in proliferation of NSPCs, we suggest that Neil3 and Ape2 have similar functions in 
maintaining DNA integrity in proliferating stem/progenitor cells. 
Consequences of hydantoin lesions in the genome 
Little is known about the magnitude the Sp and Gh lesions in the mammalian genome. 
Hydantoins are formed after further oxidation of 8-oxoG, which has been shown to be 1000 
times more reactive against peroxynitrite than guanine itself (Helbock et al, 1998; Uppu et al, 
1996). The first report of detection of these lesions in the mammalian genome was published 
a few months ago: Sp and Gh levels were correlated to the level of 8-oxoG, and detected with 
a frequency of one to seven lesions per 108 nucleotides in mouse colon and liver, almost 100 
times less frequent than the parental 8-oxoG lesion (Mangerich et al, 2012). While 8-oxoG is 
mildly mutagenic, leading to a G  T mutation with a frequency of less than 10 % if not 
repaired, Sp and Gh will always result in G  T or G  C mutation if left unrepaired prior 
to replication (Duarte et al, 1999; Klein et al, 1992; Cheng et al, 1992). Gh and Sp lesions 
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have shown, in contrast to 8-oxoG, to be strong replication blocks in vivo, where lesion 
bypass efficiency is sequence dependent (Henderson et al, 2002; Delaney et al, 2007; 
Henderson et al, 2003). Nei-deficient E. coli accumulates 20-fold more Sp lesions than wild-
type during oxidative stress (Hailer et al, 2005b).  
In paper III and IV we demonstrated by in vitro experiments that repair of hydantoin lesions 
in ssDNA in mouse NSPCs, thymus and spleen is mainly performed by Neil3. Even though 
the repair activity on hydantoin lesions in ssDNA was just above detection level, we detected 
a clear correlation between excision/incision activity and expression of Neil3 (paper III). 
Repair activities were in general higher for hydantoin lesions in dsDNA than ssDNA, which 
can be explained by the presence of single-strand DNA-binding proteins (SSB) and other 
proteins with affinity for ssDNA in the cell extract. SSB are abundant in the cell and can 
cover the ssDNA substrate, making it inaccessible for recognition and excision by the DNA 
glycosylase in the in vitro assay. Adding titrated competitor ssDNA to the reaction was 
essential to detect activity, but the reaction conditions might still not be optimal. 
Nevertheless, the DNA exists as a duplex in most contexts, and likely, the bulk of the DNA 
glycosylases will be engaged in the repair of lesions in dsDNA.  
Sp and Gh lesions in DNA are recognized and repaired by Nth1 and Neil1-3 in mammals, 
while only the Neils are reported to recognize hydantoins in ssDNA (Hailer et al, 2005a; Liu 
et al, 2010). Neil1 repairs Sp and Gh lesions 100-fold more efficient than its previously 
reported standard substrates Tg and 5-OHC (Krishnamurthy et al, 2008). The absence of 
repair activity of hydantoin lesions in ssDNA in NSPCs, thymus and spleen from Neil3-
deficient mice suggest either that expression of Neil1 and Neil2 is too low for efficient 
catalysis, or Neil1 and Neil2 are present, but limited to other functions or substrates in 
proliferative tissue.   
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Conclusion 
The `loss` of the active site residue Pro2 in human NEIL3 provides different catalytic 
properties than NEIL1 and NEIL2. Incision of DNA when it is in a single-stranded context 
may result in fatal strand breaks. We speculate that NEIL3 is a monofunctional glycosylase in 
vivo, recruiting downstream BER enzymes to complete the repair.  
In this study, we have shown that Neil3 is a DNA glycosylase important for proliferating 
cells. We suggest that Neil3 removes hydantoin lesions in proliferating cells to prevent 
blockage of replication, transcription, or both. We also hypothesize that Neil3 may be 
involved in region specific repair, for instance in promoters of genes involved in proliferation 
and/or differentiation.
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CONCLUDING REMARKS 
When I started working with NEIL3 some years back, there were only a few published 
reports. We cloned the sequence and had a wish to express and purify the protein. NEIL3 has 
been challenging to work with. The recombinant protein formed aggregates, overexpression 
in eukaryotic cell lines was toxic, while endogenous expression in most cell types was below 
detection level. I guess I have experienced the same feeling of hopelessness as most PhD 
students do. It feels good to look back on the puzzle where we, together with many other 
groups have contributed to find the pieces. There is still much to be unraveled about NEIL3. 
When the NEILs were discovered, they were first suggested to be back up enzymes for 
OGG1 and NTH1. With new evidence, like the lack of cancer phenotypes in DNA 
glycosylase deficient mice strands, we speculate that BER is not simply repair, but a finely 
tuned system for regulation of DNA base modifications in specific contexts to maintain cell 
properties and tissue homeostasis, i.e. maintenance of epigenetic state. BER is highly 
regulated and all the contributors probably have their unique function. Factors like cell type, 
cell cycle stage, cell maturity, proliferation/differentiation stage, tissue type, chromatin state 
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as well as extent, type, and location of lesions will likely influence on the choice of enzymes 
and repair pathways. Repair of oxidative damage is of vital importance for the organism, and 
the DNA glycosylases have evolved to be flexible so they can step in for each other if one is 
defect as well as during massive ROS induction. 
Our plans for future experiments are many. We have been trying to crystallize the 
glycosylase domain of human NEIL3 for years without success. A crystal structure can give 
us important information about the architecture of the active site and the base recognition 
pocket with the 30 nucleotide non-conserved loop, unique for NEIL3. The recent evidence of 
the presence of Sp and Gh lesions in mammalian tissue supports that base excision indeed 
may be the canonical function of Neil3. As a continuance of paper IV, it would be valuable if 
we were able to detect Sp and Gh lesions in brain tissue and neurospheres from Neil3-
deficient mice. Further, we wish to expose Neil3-/-/Ogg1-/- mice to HI. We predict these mice 
to accumulate even greater amount of hydantoins, due to their reduced capacity of 8-oxoG 
removal. Implementing detection of Sp and Gh in the genome, as well as a mouse model with 
a more pronounced phenotype will be useful tools in our search for the mechanisms leading 
to impairment in proliferation.  
After my dissertation, I will start working on another interesting feature of NEIL3: Its 
involvement during Human Immunodeficiency virus (HIV) infection. This will be 
collaboration with Stephen Goff’s lab at Columbia University. NEIL3 has been suggested to 
be a host factor for HIV, after it was picked up in a genome wide siRNA screen in 2008 
(Zhou et al, 2008). Later, also other components of BER, including OGG1, NEIL1, NTH1 
and POL , have been implicated a role in the viral life cycle (Espeseth et al, 2011; Yoder et 
al, 2011). NEIL3 mRNA is strongly upregulated in CD4+ cells of HIV patients, and its 
expression correlates with virus count (personal communication with Pål Aukrust, 
Rikshospitalet). Further, we have transduced wild-type and Neil3-deficient MEF cells with a 
lentiviral vector system, derived from HIV, and found that Neil3-deficient cells have a 
magnitude lover transduction rate than the wild-type cells (own unpublished results). With 
our knowledge on NEIL3 and BER, and with the Goff labs expertise on HIV, we hope to get 
an insight into the use of DNA glycosylases in the lentivirus life cycle


REFERENCES 
Ahmad R, Rasheed Z & Ahsan H (2009) Biochemical and cellular toxicology of 
peroxynitrite: implications in cell death and autoimmune phenomenon. 
Immunopharmacology and immunotoxicology 31: 388–96 
Ahmed S (2009) The culture of neural stem cells. Journal of cellular biochemistry 106: 1–6 
Al-Tassan N, Chmiel NH, Maynard J, Fleming N, Livingston AL, Williams GT, Hodges AK, 
Davies DR, David SS, Sampson JR & Cheadle JP (2002) Inherited variants of MYH 
associated with somatic G:C-->T:A mutations in colorectal tumors. Nature genetics 30:
227–32 
Arai T, Kelly VP, Minowa O, Noda T & Nishimura S (2006) The study using wild-type and 
Ogg1 knockout mice exposed to potassium bromate shows no tumor induction despite 
an extensive accumulation of 8-hydroxyguanine in kidney DNA. Toxicology 221: 179–
86 
Arvidsson A, Collin T, Kirik D, Kokaia Z & Lindvall O (2002) Neuronal replacement from 
endogenous precursors in the adult brain after stroke. Nature medicine 8: 963–70 
Audebert M, Radicella JP & Dizdaroglu M (2000) Effect of single mutations in the OGG1 
gene found in human tumors on the substrate specificity of the Ogg1 protein. Nucleic 
acids research 28: 2672–8 
Bailly V, Derydt M & Verly WG (1989) Delta-elimination in the repair of AP 
(apurinic/apyrimidinic) sites in DNA. The Biochemical journal 261: 707–13 
Bailly V & Verly WG (1987) Escherichia coli endonuclease III is not an endonuclease but a 
beta-elimination catalyst. The Biochemical journal 242: 565–72 
Bandaru V, Sunkara S, Wallace SS & Bond JP (2002) A novel human DNA glycosylase that 
removes oxidative DNA damage and is homologous to Escherichia coli endonuclease 
VIII. DNA Repair 1: 517–529 
Bandaru V, Zhao X, Newton MR, Burrows CJ & Wallace SS (2007) Human endonuclease 
VIII-like (NEIL) proteins in the giant DNA Mimivirus. DNA Repair 6: 1629–1641 
Banerjee A, Santos WL & Verdine GL (2006) Structure of a DNA glycosylase searching for 
lesions. Science 311: 1153–7 
Banerjee D, Mandal SM, Das A, Hegde ML, Das S, Bhakat KK, Boldogh I, Sarkar PS, Mitra 
S & Hazra TK (2011) Preferential repair of oxidized base damage in the transcribed 
genes of mammalian cells. The Journal of biological chemistry 286: 6006–16 
Barnes DE & Lindahl T (2004) Repair and genetic consequences of endogenous DNA base 
damage in mammalian cells. Annual review of genetics 38: 445–76 


Barry KH, Koutros S, Berndt SI, Andreotti G, Hoppin JA, Sandler DP, Burdette LA, Yeager 
M, Freeman LEB, Lubin JH, Ma X, Zheng T & Alavanja MCR (2011) Genetic variation 
in base excision repair pathway genes, pesticide exposure, and prostate cancer risk. 
Environmental health perspectives 119: 1726–32 
Le Belle JE, Orozco NM, Paucar AA, Saxe JP, Mottahedeh J, Pyle AD, Wu H & Kornblum 
HI (2011) Proliferative neural stem cells have high endogenous ROS levels that regulate 
self-renewal and neurogenesis in a PI3K/Akt-dependant manner. Cell stem cell 8: 59–71 
Bhakat KK, Hazra TK & Mitra S (2004) Acetylation of the human DNA glycosylase NEIL2 
and inhibition of its activity. Nucleic acids research 32: 3033–9 
Bhakat KK, Mokkapati SK, Boldogh I, Hazra TK & Mitra S (2006) Acetylation of Human 8-
Oxoguanine-DNA Glycosylase by p300 and Its Role in 8-Oxoguanine Repair In Vivo. 
Molecular and Cellular Biology 26: 1654–1665 
Bjorâs M, Luna L, Johnsen B, Hoff E, Haug T, Rognes T & Seeberg E (1997) Opposite base-
dependent reactions of a human base excision repair enzyme on DNA containing 7,8-
dihydro-8-oxoguanine and abasic sites. The EMBO journal 16: 6314–22 
Black HS (1987) Potential involvement of free radical reactions in ultraviolet light-mediated 
cutaneous damage. Photochemistry and photobiology 46: 213–21 
Blainey PC, Luo G, Kou SC, Mangel WF, Verdine GL, Bagchi B & Xie XS (2009) 
Nonspecifically bound proteins spin while diffusing along DNA. Nature structural & 
molecular biology 16: 1224–9 
Blainey PC, van Oijen AM, Banerjee A, Verdine GL & Xie XS (2006) A base-excision 
DNA-repair protein finds intrahelical lesion bases by fast sliding in contact with DNA. 
Proceedings of the National Academy of Sciences of the United States of America 103:
5752–7 
Bohr VA, Ottersen OP & Tønjum T (2007) Genome instability and DNA repair in brain, 
ageing and neurological disease. Neuroscience 145: 1183–6 
Brettel K & Byrdin M (2010) Reaction mechanisms of DNA photolyase. Current opinion in 
structural biology 20: 693–701 
Broderick P, Bagratuni T, Vijayakrishnan J, Lubbe S, Chandler I & Houlston RS (2006) 
Evaluation of NTHL1, NEIL1, NEIL2, MPG, TDG, UNG and SMUG1 genes in familial 
colorectal cancer predisposition. BMC cancer 6: 243 
Brown JA, Pack LR, Sanman LE & Suo Z (2011) Efficiency and fidelity of human DNA 
polymerases  and  during gap-filling DNA synthesis. DNA repair 10: 24–33 
Brunt KR, Weisel RD & Li R (2012) Stem cells and regenerative medicine — future 
perspectives. Canadian Journal of Physiology and Pharmacology 335: 327–335 
	

Burgess S, Jaruga P, Dodson ML, Dizdaroglu M & Lloyd RS (2002) Determination of active 
site residues in Escherichia coli endonuclease VIII. Journal of bacteriology. 277: 2938–
2944 
Burkovics P, Hajdú I, Szukacsov V, Unk I & Haracska L (2009) Role of PCNA-dependent 
stimulation of 3’-phosphodiesterase and 3'-5' exonuclease activities of human Ape2 in 
repair of oxidative DNA damage. Nucleic acids research 37: 4247–55 
Burney S, Caulfield JL, Niles JC, Wishnok JS & Tannenbaum SR (1999) The chemistry of 
DNA damage from nitric oxide and peroxynitrite. Mutation research 424: 37–49 
Caldecott KW, Aoufouchi S, Johnson P & Shall S (1996) XRCC1 polypeptide interacts with 
DNA polymerase beta and possibly poly (ADP-ribose) polymerase, and DNA ligase III 
is a novel molecular “nick-sensor” in vitro. Nucleic acids research 24: 4387–94 
Campalans A, Marsin S, Nakabeppu Y, O’connor TR, Boiteux S & Radicella JP (2005) 
XRCC1 interactions with multiple DNA glycosylases: a model for its recruitment to 
base excision repair. DNA repair 4: 826–35 
Canugovi C, Yoon JS, Feldman NH, Croteau DL, Mattson MP & Bohr VA (2012) 
Endonuclease VIII-like 1 (NEIL1) promotes short-term spatial memory retention and 
protects from ischemic stroke-induced brain dysfunction and death in mice. Proceedings 
of the National Academy of Sciences of the United States of America 1: 1–6 
Cardozo-pelaez F, Sanchez-contreras M & Nevin ABC (2012) Ogg1 null mice exhibit age-
associated loss of the nigrostriatal pathway and increased sensitivity to MPTP. 
Neurochemistry International 61: 721–730 
Chan MK, Ocampo-Hafalla MT, Vartanian V, Jaruga P, Kirkali G, Koenig KL, Brown S, 
Lloyd RS, Dizdaroglu M & Teebor GW (2009) Targeted deletion of the genes encoding 
NTH1 and NEIL1 DNA N-glycosylases reveals the existence of novel carcinogenic 
oxidative damage to DNA. DNA repair 8: 786–94 
Chen DS, Herman T & Demple B (1991) Two distinct human DNA diesterases that 
hydrolyze 3’-blocking deoxyribose fragments from oxidized DNA. Nucleic acids 
research 19: 5907–14 
Cheng KC, Cahill DS, Kasai H, Nishimura S & Loeb LA (1992) 8-Hydroxyguanine, an 
abundant form of oxidative DNA damage, causes G----T and A----C substitutions. The 
Journal of biological chemistry 267: 166–72 
Chetsanga CJ & Lindahl T (1979) Release of l-methylguanine residues whose imidazole 
rings have been opened from damaged DNA by a DNA glycosylase from Escherichia 
coli. Nucleic Acids Research 6: 3673–3684 
Cho YM, Kwon S, Pak YK, Seol HW, Choi YM, Park DJ, Park KS & Lee HK (2006) 
Dynamic changes in mitochondrial biogenesis and antioxidant enzymes during the 



spontaneous differentiation of human embryonic stem cells. Biochemical and 
biophysical research communications 348: 1472–8 
Clauson CL, Oestreich KJ, Austin JW & Doetsch PW (2010) Abasic sites and strand breaks 
in DNA cause transcriptional mutagenesis in Escherichia coli. Proceedings of the 
National Academy of Sciences of the United States of America 107: 3657–62 
Coppedè F, Ceravolo R, Migheli F, Fanucchi F, Frosini D, Siciliano G, Bonuccelli U & 
Migliore L (2010) The hOGG1 Ser326Cys polymorphism is not associated with 
sporadic Parkinson’s disease. Neuroscience letters 473: 248–51 
Coppedè F, Mancuso M, Lo Gerfo A, Carlesi C, Piazza S, Rocchi A, Petrozzi L, Nesti C, 
Micheli D, Bacci A, Migliore L, Murri L & Siciliano G (2007a) Association of the 
hOGG1 Ser326Cys polymorphism with sporadic amyotrophic lateral sclerosis. 
Neuroscience letters 420: 163–8 
Coppedè F, Mancuso M, Lo Gerfo A, Manca ML, Petrozzi L, Migliore L, Siciliano G & 
Murri L (2007b) A Ser326Cys polymorphism in the DNA repair gene hOGG1 is not 
associated with sporadic Alzheimer’s disease. Neuroscience letters 414: 282–5 
Coppedè F & Migliore L (2009) DNA damage and repair in Alzheimer’s disease. Current 
Alzheimer Research 6: 36–47 
Cortázar D, Kunz C, Selfridge J, Lettieri T, Saito Y, MacDougall E, Wirz A, Schuermann D, 
Jacobs AL, Siegrist F, Steinacher R, Jiricny J, Bird A & Schär P (2011) Embryonic 
lethal phenotype reveals a function of TDG in maintaining epigenetic stability. Nature
470: 419–23 
Crick F (1974) The double helix: a personal view. Nature 248: 766 – 769 
Dahlmann HA, Vaidyanathan VG & Sturla SJ (2010) Investigating the Biochemical Impact 
of DNA Damage with Structure-Based Probes: Abasic Sites, Photodimers, Alkylation 
Adducts, and Oxidative Lesions. National Institute of Health 48: 9347–9359 
Dalhus B, Laerdahl JK, Backe PH & Bjørås M (2009) DNA base repair--recognition and 
initiation of catalysis. FEMS microbiology reviews 33: 1044–78 
Dallosso AR, Dolwani S, Jones N, Jones S, Colley J, Maynard J, Idziaszczyk S, Humphreys 
V, Arnold J, Donaldson A, Eccles D, Ellis A, Evans DG, Frayling IM, Hes FJ, Houlston 
RS, Maher ER, Nielsen M, Parry S, Tyler E, et al (2008) Inherited predisposition to 
colorectal adenomas caused by multiple rare alleles of MUTYH but not OGG1, NUDT1, 
NTH1 or NEIL 1, 2 or 3. Gut 57: 1252–1255 
Delaney S, Neeley WL, Delaney JC & Essigmann JM (2007) The substrate specificity of 
MutY for hyperoxidized guanine lesions in vivo. Biochemistry 46: 1448–55 
Dhénaut a, Boiteux S & Radicella JP (2000) Characterization of the hOGG1 promoter and its 
expression during the cell cycle. Mutation research 461: 109–18 


Dianov G & Lindahl T (1994) Reconstitution of the DNA base excision-repair pathway. 
Current biology 4: 1069–76 
Diderich K, Alanazi M & Hoeijmakers JHJ (2011) Premature aging and cancer in nucleotide 
excision repair-disorders. DNA repair 10: 772–80 
Dizdaroglu M, Karahalil B, Sentürker S, Buckley TJ & Roldán-Arjona T (1999) Excision of 
products of oxidative DNA base damage by human NTH1 protein. Biochemistry 38:
243–6 
Dou H, Mitra S & Hazra TK (2003a) Repair of oxidized bases in DNA bubble structures by 
human DNA glycosylases NEIL1 and NEIL2. The Journal of biological chemistry 278:
49679–84 
Dou H, Mitra S & Hazra TK (2003b) Repair of oxidized bases in DNA bubble structures by 
human DNA glycosylases NEIL1 and NEIL2. The Journal of biological chemistry 278:
49679–49684 
Dou H, Theriot C a, Das A, Hegde ML, Matsumoto Y, Boldogh I, Hazra TK, Bhakat KK & 
Mitra S (2008) Interaction of the human DNA glycosylase NEIL1 with proliferating cell 
nuclear antigen. The potential for replication-associated repair of oxidized bases in 
mammalian genomes. The Journal of biological chemistry 283: 3130–40 
Doublie S, Bandaru V, Bond JP & Wallace SS (2004) The crystal structure of human 
endonuclease VIII-like 1 (NEIL1) reveals a zincless finger motif required for 
glycosylase activity. Proceedings of the National Academy of Sciences of the United 
States of America 101: 10284–10289 
Drabløs F, Feyzi E, Aas PA, Vaagbø CB, Kavli B, Bratlie MS, Peña-Diaz J, Otterlei M, 
Slupphaug G & Krokan HE (2004) Alkylation damage in DNA and RNA--repair 
mechanisms and medical significance. DNA repair 3: 1389–407 
Duarte V, Muller JG & Burrows CJ (1999) Insertion of dGMP and dAMP during in vitro 
DNA synthesis opposite an oxidized form of 7,8-dihydro-8-oxoguanine. Nucleic Acids 
Research 27: 496–502 
Dunn AR, Kad NM, Nelson SR, Warshaw DM & Wallace SS (2011) Single Qdot-labeled 
glycosylase molecules use a wedge amino acid to probe for lesions while scanning along 
DNA. Nucleic acids research 39: 7487–98 
Eker APM, Quayle C, Chaves I & van der Horst GTJ (2009) DNA repair in mammalian cells: 
Direct DNA damage reversal: elegant solutions for nasty problems. Cellular and 
molecular life sciences 66: 968–80 
Endres M, Biniszkiewicz D, Sobol RW, Harms C, Ahmadi M, Lipski A, Katchanov J, 
Mergenthaler P, Dirnagl U, Wilson SH, Meisel A & Jaenisch R (2004) Increased 
postischemic brain injury in mice deficient in uracil-DNA glycosylase. The Journal of 
Clinical Investigation 113: 1711–1721 


Espeseth AS, Fishel R, Hazuda D, Huang Q, Xu M, Yoder K & Zhou H (2011) siRNA 
screening of a targeted library of DNA repair factors in HIV infection reveals a role for 
base excision repair in HIV integration. PloS one 6: e17612 
Falnes PØ, Klungland A & Alseth I (2007) Repair of methyl lesions in DNA and RNA by 
oxidative demethylation. Neuroscience 145: 1222–32 
Fan J & Wilson DM (2005) Protein-protein interactions and posttranslational modifications 
in mammalian base excision repair. Free radical biology & medicine 38: 1121–38 
Forsbring M, Vik ES, Dalhus B, Karlsen TH, Bergquist A, Schrumpf E, Bjørås M, Boberg 
KM & Alseth I (2009) Catalytically impaired hMYH and NEIL1 mutant proteins 
identified in patients with primary sclerosing cholangitis and cholangiocarcinoma. 
Carcinogenesis 30: 1147–54 
Fortini P & Dogliotti E (2007) Base damage and single-strand break repair: mechanisms and 
functional significance of short- and long-patch repair subpathways. DNA repair 6: 398–
409 
Freeman MR (2010) Specification and morphogenesis of astrocytes. Science 330: 774–8 
Friedman JI & Stivers JT (2010) Detection of damaged DNA bases by DNA glycosylase 
enzymes. Biochemistry 49: 4957–67 
Fromme JC, Banerjee A & Verdine GL (2004) DNA glycosylase recognition and catalysis. 
Current opinion in structural biology 14: 43–9 
Gao Y, Katyal S, Lee Y, Zhao J, Rehg JE, Russell HR & McKinnon PJ (2011) DNA ligase 
III is critical for mtDNA integrity but not Xrcc1-mediated nuclear DNA repair. Nature
471: 240–4 
Guikema JEJ, Gerstein RM, Linehan EK, Cloherty EK, Evan-Browning E, Tsuchimoto D, 
Nakabeppu Y & Schrader CE (2011) Apurinic/apyrimidinic endonuclease 2 is necessary 
for normal B cell development and recovery of lymphoid progenitors after 
chemotherapeutic challenge. Journal of immunology 186: 1943–50 
Hadi MZ & Wilson DM (2000) Second human protein with homology to the Escherichia coli 
abasic endonuclease exonuclease III. Environmental and molecular mutagenesis 36:
312–24 
Hailer MK, Slade PG, Martin BD, Rosenquist TA & Sugden KD (2005a) Recognition of the 
oxidized lesions spiroiminodihydantoin and guanidinohydantoin in DNA by the 
mammalian base excision repair glycosylases NEIL1 and NEIL2. DNA repair 4: 41–50 
Hailer MK, Slade PG, Martin BD & Sugden KD (2005b) Nei Deficient Escherichia coli Are 
Sensitive to Chromate and Accumulate the Oxidized Guanine Lesion 
Spiroiminodihydantoin. Chemical research in toxicology 18: 1378–1383 


Halliwell B (2006) Oxidative stress and neurodegeneration: where are we now? Journal of 
neurochemistry 97: 1634–58 
Harman D (1981) The aging process. Proceedings of the National Academy of Sciences of the 
United States of America 78: 7124–7128 
Hartlerode AJ & Scully R (2009) Mechanisms of double-strand break repair in somatic 
mammalian cells. The Biochemical journal 423: 157–68 
Haynes C, Oldfield CJ, Ji F, Klitgord N, Cusick ME, Radivojac P, Uversky VN, Vidal M & 
Iakoucheva LM (2006) Intrinsic disorder is a common feature of hub proteins from four 
eukaryotic interactomes. PLoS computational biology 2: 890–902 
Hazra TK, Izumi T, Boldogh I, Imhoff B, Kow YW, Jaruga P, Dizdaroglu M & Mitra S 
(2002a) Identification and characterization of a human DNA glycosylase for repair of 
modified bases in oxidatively damaged DNA. Proceedings of the National Academy of 
Sciences of the United States of America 99: 3523–3528 
Hazra TK, Kow YW, Hatahet Z, Imhoff B, Boldogh I, Mokkapati SK, Mitra S & Izumi T 
(2002b) Identification and characterization of a novel human DNA glycosylase for 
repair of cytosine-derived lesions. Journal of Biological Chemistry. 277: 30417–30420 
Hegde ML, Hazra TK & Mitra S (2008a) Early steps in the DNA base excision/single-strand 
interruption repair pathway in mammalian cells. Cell research 18: 27–47 
Hegde ML, Hazra TK & Mitra S (2010) Functions of disordered regions in mammalian early 
base excision repair proteins. Cellular and molecular life sciences 67: 3573–87 
Hegde ML, Mantha AK, Hazra TK, Bhakat KK, Mitra S & Szczesny B (2012) Oxidative 
genome damage and its repair: Implications in aging and neurodegenerative diseases. 
Mechanisms of ageing and development 133: 157–168 
Hegde ML, Theriot CA, Das A, Hegde PM, Guo Z, Gary RK, Hazra TK, Shen B & Mitra S 
(2008b) Physical and functional interaction between human oxidized base-specific DNA 
glycosylase NEIL1 and flap endonuclease 1. The Journal of biological chemistry 283:
27028–37 
Helbock HJ, Beckman KB, Shigenaga MK, Walter PB, Woodall a a, Yeo HC & Ames BN 
(1998) DNA oxidation matters: the HPLC-electrochemical detection assay of 8-oxo-
deoxyguanosine and 8-oxo-guanine. Proceedings of the National Academy of Sciences 
of the United States of America 95: 288–93 
Henderson PT, Delaney JC, Gu F, Tannenbaum SR & Essigmann JM (2002) Oxidation of 
7,8-dihydro-8-oxoguanine affords lesions that are potent sources of replication errors in 
vivo. Biochemistry 41: 914–21 


Henderson PT, Delaney JC, Muller JG, Neeley WL, Tannenbaum SR, Burrows CJ & 
Essigmann JM (2003) The hydantoin lesions formed from oxidation of 7,8-dihydro-8-
oxoguanine are potent sources of replication errors in vivo. Biochemistry 42: 9257–62 
Hendrich B, Hardeland U, Ng HH, Jiricny J & Bird A (1999) The thymine glycosylase 
MBD4 can bind to the product of deamination at methylated CpG sites. Nature 401:
301–4 
Hildrestrand GA, Neurauter CG, Diep DB, Castellanos CG, Krauss S, Bjoras M & Luna L 
(2009) Expression patterns of Neil3 during embryonic brain development and neoplasia. 
BMC Neuroscience 10: 45 
Hoeijmakers JHJ (2001) Genome maintenance mechanisms for preventing cancer. Nature
411: 366–374 
Hoeijmakers JHJ (2009) DNA damage, aging, and cancer. The New England journal of 
medicine 361: 1475–85 
Ide Y, Tsuchimoto D, Tominaga Y, Nakashima M, Watanabe T, Sakumi K, Ohno M & 
Nakabeppu Y (2004) Growth retardation and dyslymphopoiesis accompanied by G2/M 
arrest in APEX2-null mice. Blood 104: 4097–103 
Imai K, Sarker AH, Akiyama K, Ikeda S, Yao M, Tsutsui K, Shohmori T & Seki S (1998) 
Genomic structure and sequence of a human homologue (NTHL1/NTH1) of Escherichia 
coli endonuclease III with those of the adjacent parts of TSC2 and SLC9A3R2 genes. 
Gene 222: 287–95 
Ito K, Hirao A, Arai F, Takubo K, Matsuoka S, Miyamoto K, Ohmura M, Naka K, Hosokawa 
K, Ikeda Y & Suda T (2006) Reactive oxygen species act through p38 MAPK to limit 
the lifespan of hematopoietic stem cells. Nature medicine 12: 446–51 
Iwakuma T, Sakumi K, Nakatsuru Y, Kawate H, Igarashi H, Shiraishi A, Tsuzuki T, 
Ishikawa T & Sekiguchi M (1997) High incidence of nitrosamine-induced tumorigenesis 
in mice lacking DNA repair methyltransferase. Carcinogenesis 18: 1631–5 
Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH, Gassmann M, Gearhart 
JD, Lawler AM, Yu AY & Semenza GL (1998) Cellular and developmental control of O 
2 homeostasis by hypoxia-inducible factor 1. Genes and development 12: 149–162 
Jacobs AL & Schär P (2012) DNA glycosylases: in DNA repair and beyond. Chromosoma
121: 1–20 
Jasperson KW, Tuohy TM, Neklason DW & Burt RW (2010) Hereditary and familial colon 
cancer. Gastroenterology 138: 2044–58 
Jensen JB & Parmar M (2006) Strengths and limitations of the neurosphere culture system. 
Molecular neurobiology 34: 153–61 


Jeppesen DK, Bohr VA & Stevnsner T (2011) DNA repair deficiency in neurodegeneration. 
Progress in neurobiology 94: 166–200 
Jiricny J (2006) The multifaceted mismatch-repair system. Nature reviews. Molecular cell 
biology 7: 335–46 
Jones S, Emmerson P, Maynard J, Best JM, Jordan S, Williams GT, Sampson JR & Cheadle 
JP (2002) Biallelic germline mutations in MYH predispose to multiple colorectal 
adenoma and somatic G:C-->T:A mutations. Human molecular genetics 11: 2961–7 
Kanavy HE & Gerstenblith MR (2011) Ultraviolet radiation and melanoma. Seminars in 
cutaneous medicine and surgery 30: 222–8 
Karahalil B, de Souza-Pinto NC, Parsons JL, Elder RH & Bohr VA (2003) Compromised 
incision of oxidized pyrimidines in liver mitochondria of mice deficient in NTH1 and 
OGG1 glycosylases. The Journal of biological chemistry 278: 33701–7 
Karimi-Busheri F, Daly G, Robins P, Canas B, Pappin DJC, Sgouros J, Miller GG, Fakhrai 
H, Davis EM, Beau MML & Weinfeld M (1999) Molecular Characterization of a 
Human DNA Kinase. The Journal of biological chemistry 274: 24187–24194 
Kasai H, Nishimura S & Division B (1984) Hydroxylation of deoxyguanosine at the C-8 
position by ascorbic acid and other reducing agents. Nucleic acid research 12: 2137–
2145 
Kasparek TR & Humphrey TC (2011) DNA double-strand break repair pathways, 
chromosomal rearrangements and cancer. Seminars in cell & developmental biology 22:
886–97 
Kauffmann A, Rosselli F, Lazar V, Winnepenninckx V, Mansuet-Lupo A, Dessen P, van den 
Oord JJ, Spatz A & Sarasin A (2008) High expression of DNA repair pathways is 
associated with metastasis in melanoma patients. Oncogene 27: 565–73 
Klaunig JE, Wang Z, Pu X & Zhou S (2011) Oxidative stress and oxidative damage in 
chemical carcinogenesis. Toxicology and applied pharmacology 254: 86–99 
Klein JC, Bleeker MJ, Saris CP, Roelen HC, Brugghe HF, van den Elst H, van der Marel GA, 
van Boom JH, Westra JG & Kriek E (1992) Repair and replication of plasmids with site-
specific 8-oxodG and 8-AAFdG residues in normal and repair-deficient human cells. 
Nucleic acids research 20: 4437–43 
Klungland A & Lindahl T (1997) Second pathway for completion of human DNA base 
excision-repair: reconstitution with purified proteins and requirement for DNase IV 
(FEN1). The EMBO journal 16: 3341–8 
Klungland A, Rosewell I, Hollenbach S, Larsen E, Daly G, Epe B, Seeberg E, Lindahl T & 
Barnes DE (1999) Accumulation of premutagenic DNA lesions in mice defective in 


removal of oxidative base damage. Proceedings of the National Academy of Sciences of 
the United States of America 96: 13300–13305 
Kow YW & Wallace SS (1987) Mechanism of action of Escherichia coli endonuclease III. 
Biochemistry 26: 8200–8206 
Krishnamurthy N, Zhao X, Burrows CJ & David SS (2008) Superior Removal of Hydantoin 
Lesions Relative to Other Oxidized Bases by the Human DNA Glycosylase hNEIL1. 
Biochemistry 47: 7137–7146 
Krokan HE, Standal R & Slupphaug G (1997) DNA glycosylases in the base excision repair 
of DNA. Biochemical Journal 16: 1–16 
Kubota Y, Nash RA, Klungland A, Schar P, Barnes DE & Lindahl T (1996) Reconstitution 
excision-repair purified proteins: polymerase protein. The EMBO journal 15: 6662–
6670 
Lan J, Li W, Zhang F, Sun FY, Nagayama T, O’Horo C & Chen J (2003) Inducible repair of 
oxidative DNA lesions in the rat brain after transient focal ischemia and reperfusion. 
Journal of cerebral blood flow and metabolism 23: 1324–39 
Lau a Y, Schärer OD, Samson L, Verdine GL & Ellenberger T (1998) Crystal structure of a 
human alkylbase-DNA repair enzyme complexed to DNA: mechanisms for nucleotide 
flipping and base excision. Cell 95: 249–58 
Lawson LJ, Perry VH & Gordon S (1992) Turnover of resident microglia in the normal adult 
mouse brain. Neuroscience 48: 405–15 
Li H, Hao X, Zhang W, Wei Q & Chen K (2008) The hOGG1 Ser326Cys polymorphism and 
lung cancer risk: a meta-analysis. Cancer epidemiology, biomarkers & prevention 17:
1739–45 
Li P, Hu X, Gan Y, Gao Y, Liang W & Chen J (2011) Mechanistic insight into DNA damage 
and repair in ischemic stroke: exploiting the base excision repair pathway as a model of 
neuroprotection. Antioxidants & redox signaling 14: 1905–18 
Lindahl T (1993) Instability and decay of the primary structure of DNA. Nature 362: 13300–
13305 
Lindahl T & Nyberg B (1972) Rate of depurination of native deoxiribonucleic acid. 
Biochemistry 11: 3610–3618 
Liu D, Croteau DL, Souza-Pinto N, Pitta M, Tian J, Wu C, Jiang H, Mustafa K, Keijzers G, 
Bohr VA & Mattson MP (2011) Evidence that OGG1 glycosylase protects neurons 
against oxidative DNA damage and cell death under ischemic conditions. Journal of 
cerebral blood flow and metabolism 31: 680–92 


Liu M, Bandaru V, Bond JP, Jaruga P, Zhao X, Christov PP, Burrows CJ, Rizzo CJ, 
Dizdaroglu M & Wallace SS (2010) The mouse ortholog of NEIL3 is a functional DNA 
glycosylase in vitro and in vivo. Proceedings of the National Academy of Sciences of the 
United States of America 107: 4925–4930 
Liu M, Bandaru V, Holmes A, Averill AM, Cannan W & Wallace SS (2012) Expression and 
purification of active mouse and human NEIL3 proteins. Protein expression and 
purification 84: 130–139 
Liu X & Roy R (2002) Truncation of Amino-terminal Tail Stimulates Activity of Human 
Endonuclease III (hNTH1). Journal of Molecular Biology 321: 265–276 
Lodish H, Berk A, Matsudeira P, Kaiser C, Kreiger M & Scott M (2004) Molecular cell 
biology 
van Loon B, Markkanen E & Hübscher U (2010) Oxygen as a friend and enemy: How to 
combat the mutational potential of 8-oxo-guanine. DNA repair 9: 604–16 
Ludwig D, MacInnes M, Takiguchi Y, Purtymun P, Henrie M, Flannery M, Meneses J, 
Pedersen R & Chen D (1998) A murine AP-endonuclease gene-targeted deficiency with 
post-implantation embryonic progression and ionizing radiation sensitivity. Mutatation 
research 1: 17–29 
Luna L, Bjørås M, Hoff E, Rognes T & Seeberg E (2000) Cell-cycle regulation, intracellular 
sorting and induced overexpression of the human NTH1 DNA glycosylase involved in 
removal of formamidopyrimidine residues from DNA. Mutation research 460: 95–104 
Magistretti PJ & Pellerin L (1996) Cellular bases of brain energy metabolism and their 
relevance to functional brain imaging: evidence for a prominent role of astrocytes. 
Cerebral cortex 6: 50–61 
Mangerich A, Knutson CG, Parry NM, Muthupalani S, Ye W & Prestwich E (2012) 
Infection-induced colitis in mice causes dynamic and tissue-specific changes in stress 
response and DNA damage leading to colon cancer. Proceedings of the National 
Academy of Sciences of the United States of America 109:
Mao G, Pan X, Zhu B-B, Zhang Y, Yuan F, Huang J, Lovell MA, Lee MP, Markesbery WR, 
Li GM & Gu L (2007) Identification and characterization of OGG1 mutations in patients 
with Alzheimer’s disease. Nucleic acids research 35: 2759–66 
Marenstein DR, Ocampo MT, Chan MK, Altamirano A, Basu AK, Boorstein RJ, 
Cunningham RP & Teebor GW (2001) Stimulation of human endonuclease III by Y 
box-binding protein 1 (DNA-binding protein B). Interaction between a base excision 
repair enzyme and a transcription factor. The Journal of biological chemistry 276:
21242–9 


Martino G, Pluchino S, Bonfanti L & Schwartz M (2011) Brain regeneration in physiology 
and pathology: the immune signature driving therapeutic plasticity of neural stem cells. 
Physiological reviews 91: 1281–304 
Matsumoto Y & Kim K (1995) Excision of deoxyribose phosphate residues by DNA 
polymerase beta during DNA repair. Science 269: 699–702 
Matsumoto Y, Kim K, Hurwitz J, Gary R, Levin DS, Tomkinson AE & Park MS (1999) 
Reconstitution of proliferating cell nuclear antigen-dependent repair of 
apurinic/apyrimidinic sites with purified human proteins. The Journal of biological 
chemistry 274: 33703–8 
Mazumdar J, O’Brien WT, Johnson RS, LaManna JC, Chavez JC, Klein PS & Simon MC 
(2010) O2 regulates stem cells through Wnt/-catenin signalling. Nature cell biology 12:
1007–13 
Melamede RJ, Hatahet Z, Kow YW, Ide H & Wallace SS (1994) Isolation and 
characterization of endonuclease VIII from Escherichia coli. Biochemistry 33: 1255–64 
Minowa O, Arai T, Hirano M, Monden Y, Nakai S, Fukuda M, Itoh M, Takano H, Hippou Y, 
Aburatani H, Masumura K, Nohmi T, Nishimura S & Noda T (2000) Mmh/Ogg1 gene 
inactivation results in accumulation of 8-hydroxyguanine in mice. Proceedings of the 
National Academy of Sciences of the United States of America 97: 4156–4161 
Morgan WF & Sowa MB (2005) Effects of ionizing radiation in nonirradiated cells. 
Proceedings of the National Academy of Sciences of the United States of America 102:
14127–8 
Morland I, Luna L, Gustad E, Seeberg E & Bjørås M (2005) Product inhibition and 
magnesium modulate the dual reaction mode of hOgg1. DNA repair 4: 381–7 
Morland I, Rolseth V, Luna L, Rognes T, Bjoras M & Seeberg E (2002) Human DNA 
glycosylases of the bacterial Fpg/MutM superfamily: an alternative pathway for the 
repair of 8-oxoguanine and other oxidation products in DNA. Nucleic Acids Research
30: 4926–4936 
Mullen GP & Wilson SH (1997) New Concepts in Biochemistry DNA Polymerase in Abasic 
Site Repair
: A Structurally Conserved Helix-Hairpin-Helix Motif in Lesion Detection 
by Base Excision Repair. Biochemistry 36: 4713–4725 
Muller C, Paupert J, Monferran S & Salles B (2005) The Double Life of the Ku Protein. Cell 
cycle 4: 438–441 
Munk BH, Burrows CJ & Schlegel HB (2008) An exploration of mechanisms for the 
transformation of 8-oxoguanine to guanidinohydantoin and spiroiminodihydantoin by 
density functional theory. Journal of the American Chemical Society 130: 5245–56 
Nave KA (2010) Myelination and support of axonal integrity by glia. Nature 468: 244–52 
	

Neurauter CG, Luna L & Bjørås M (2012) Release from quiescence stimulates the expression 
of human NEIL3 under the control of the Ras dependent ERK-MAP kinase pathway. 
DNA repair 11: 401–9 
Niedernhofer LJ, Bohr VA, Sander M & Kraemer KH (2011) Xeroderma pigmentosum and 
other diseases of human premature aging and DNA repair: molecules to patients. 
Mechanisms of ageing and development 132: 340–7 
Niedernhofer LJ, Garinis GA, Raams A, Lalai AS, Robinson AR, Appeldoorn E, Odijk H, 
Oostendorp R, Ahmad A, van Leeuwen W, Theil AF, Vermeulen W, van der Horst GTJ, 
Meinecke P, Kleijer WJ, Vijg J, Jaspers NGJ & Hoeijmakers JHJ (2006) A new 
progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. 
Nature 444: 1038–43 
Nishioka K, Ohtsubo T, Oda H, Fujiwara T, Kang D, Sugimachi K & Nakabeppu Y (1999) 
Expression and differential intracellular localization of two major forms of human 8-
oxoguanine DNA glycosylase encoded by alternatively spliced OGG1 mRNAs. 
Molecular biology of the cell 10: 1637–52 
Nitti M, Furfaro AL, Cevasco C, Traverso N, Marinari UM, Pronzato MA & Domenicotti C 
(2010) PKC delta and NADPH oxidase in retinoic acid-induced neuroblastoma cell 
differentiation. Cellular signalling 22: 828–35 
Nouspikel T (2007) DNA repair in differentiated cells: some new answers to old questions. 
Neuroscience 145: 1213–21 
Nouspikel T & Hanawalt PC (2000) Terminally differentiated human neurons repair 
transcribed genes but display attenuated global DNA repair and modulation of repair 
gene expression. Molecular and cellular biology 20: 1562–70 
Nouspikel T & Hanawalt PC (2002) DNA repair in terminally differentiated cells. DNA 
repair 1: 59–75 
Odell ID, Newick K, Heintz NH, Wallace SS & Pederson DS (2010) Non-specific DNA 
binding interferes with the efficient excision of oxidative lesions from chromatin by the 
human DNA glycosylase, NEIL1. DNA repair 9: 134–43 
Odell ID, Wallace SS & Pederson DS (2012) Rules of engagement for base excision repair in 
chromatin. Journal of cellular physiology: 1–33 
Olinski R, Gackowski D, Foksinski M, Rozalski R, Roszkowski K & Jaruga P (2002) 
Oxidative DNA damage: assessment of the role in carcinogenesis, atherosclerosis, and 
acquired immunodeficiency syndrome. Free Radical Biology & Medicine 33: 192–200 
Pascucci B, Stucki M, Jo O, Dogliotti E & Hu U (1999) Long Patch Base Excision Repair 
with Purified Human Proteins. 274: 33696–33702 



Pawelczak KS, Bennett SM & Turchi JJ (2011) Coordination of DNA-PK activation and 
nuclease processing of DNA termini in NHEJ. Antioxidants & redox signaling 14:
2531–43 
Pearl LH (2000) Structure and function in the uracil-DNA glycosylase superfamily. Mutation 
research 460: 165–81 
Porecha RH & Stivers JT (2008) Uracil DNA glycosylase uses DNA hopping and short-range 
sliding to trap extrahelical uracils. Proceedings of the National Academy of Sciences of 
the United States of America 105: 10791–6 
Prakash A, Doublié S & Wallace SS (2012) The Fpg/Nei family of DNA glycosylases: 
substrates, structures, and search for damage. Progress in molecular biology and 
translational science 110: 71–91 
Prasad R, Beard WA, Strauss PR & Wilson SH (1998) Human DNA Polymerase 
Deoxyribose Phosphate Lyase. 273: 15263–15270 
Proctor RN (2012) The history of the discovery of the cigarette-lung cancer link: evidentiary 
traditions, corporate denial, global toll. Tobacco control 21: 87–91 
Puebla-Osorio N, Lacey DB, Alt FW & Zhu C (2006) Early Embryonic Lethality Due to 
Targeted Inactivation of DNA Ligase III †. 26: 3935–3941 
Rasouli-Nia A, Karimi-Busheri F & Weinfeld M (2004) Stable down-regulation of human 
polynucleotide kinase enhances spontaneous mutation frequency and sensitizes cells to 
genotoxic agents. Proceedings of the National Academy of Sciences of the United States 
of America 101: 6905–10 
Redrejo-Rodríguez M, Saint-Pierre C, Couve S, Mazouzi A, Ishchenko AA, Gasparutto D & 
Saparbaev M (2011) New insights in the removal of the hydantoins, oxidation product of 
pyrimidines, via the base excision and nucleotide incision repair pathways. PloS one 6:
e21039 
Regnell CE, Hildrestrand GA, Sejersted Y, Medin T, Moldestad O, Rolseth V, Krokeide SZ, 
Suganthan R, Luna L, Bjoras M & Bergersen LH (2012) Hippocampal Adult 
Neurogenesis Is Maintained by Neil3-Dependent Repair of Oxidative DNA Lesions in 
Neural Progenitor Cells. Cell In Press: 1–8 
Reis A & Hermanson O (2012) The DNA glycosylases OGG1 and NEIL3 influence 
differentiation potential , proliferation , and senescence-associated signs in neural stem 
cells. Biochemical and Biophysical Research Communications: 1–6 
Reynolds B & Weiss S (1992) Generation of neurons and astrocytes from isolated cells of the 
adult mammalian central nervous system. Science 255: 1707–1710 


Riley P (1994) Free radicals in biology: oxidative stress and the effects of ionizing radiation. 
International Journal of Radiation Biology 65: 27–33 
Roberts RJ & Cheng X (1998) Base flipping. Annual review of biochemistry 67: 181–98 
Robertson AB, Klungland A, Rognes T & Leiros I (2009) DNA repair in mammalian cells: 
Base excision repair: the long and short of it. Cellular and molecular life sciences 66:
981–93 
Rocha CRR, Lerner LK, Okamoto OK, Marchetto MC & Menck CFM (2012) The role of 
DNA repair in the pluripotency and differentiation of human stem cells. Mutation 
research: 1–11 
Rolseth V, Runden-Pran E, Luna L, McMurray C, Bjoras M & Ottersen OP (2008) 
Widespread distribution of DNA glycosylases removing oxidative DNA lesions in 
human and rodent brains. DNA Repair 7: 1578–1588 
Rosenquist TA, Zaika E, Fernandes AS, Zharkov DO, Miller H & Grollman AP (2003) The 
novel DNA glycosylase, NEIL1, protects mammalian cells from radiation-mediated cell 
death. DNA Repair 2: 581–591 
Russo MT, De Luca G, Degan P & Bignami M (2007) Different DNA repair strategies to 
combat the threat from 8-oxoguanine. Mutation research 614: 69–76 
Russo MT, De Luca G, Degan P, Parlanti E, Dogliotti E, Barnes DE, Lindahl T, Yang H, 
Miller JH & Bignami M (2004) Accumulation of the oxidative base lesion 8-
hydroxyguanine in DNA of tumor-prone mice defective in both the Myh and Ogg1 
DNA glycosylases. Cancer research 64: 4411–4 
Rydberg B & Lindahl T (1982) Nonenzymatic methylation of DNA by the intracellular 
methyl group donor S-adenosyl-L-methionine is a potentially mutagenic reaction. The 
EMBO journal 1: 211–216 
Sabouri Z, Okazaki I-M, Shinkura R, Begum N, Nagaoka H, Tsuchimoto D, Nakabeppu Y & 
Honjo T (2009) Apex2 is required for efficient somatic hypermutation but not for class 
switch recombination of immunoglobulin genes. International immunology 21: 947–55 
Saeed SA, Shad KF, Saleem T, Javed F & Khan MU (2007) Some new prospects in the 
understanding of the molecular basis of the pathogenesis of stroke. Experimental brain 
research. 182: 1–10 
Sakaguchi K, Ishibashi T, Uchiyama Y & Iwabata K (2009) The multi-replication protein A 
(RPA) system--a new perspective. The FEBS journal 276: 943–63 
Salganik RI (2001) The benefits and hazards of antioxidants: controlling apoptosis and other 
protective mechanisms in cancer patients and the human population. Journal of the 
American College of Nutrition 20: 464S–472S; discussion 473S–475S 


Sampath H, Batra AK, Vartanian V, Carmical JR, Prusak D, King IB, Lowell B, Earley LF, 
Wood TG, Marks DL, McCullough AK & R Stephen L (2011) Variable penetrance of 
metabolic phenotypes and development of high-fat diet-induced adiposity in NEIL1-
deficient mice. American journal of physiology. Endocrinology and metabolism 300:
E724–34 
Sampath H, McCullough AK & Lloyd RS (2012) Regulation of DNA glycosylases and their 
role in limiting disease. Free radical research 46: 460–78 
Saparbaev M, Sidorkina OM, Jurado J, Privezentzev CV, Greenberg MM & Laval J (2002) 
Repair of oxidized purines and damaged pyrimidines by E. coli Fpg protein: different 
roles of proline 2 and lysine 57 residues. Environmental and molecular mutagenesis 39:
10–17 
Sauer H, Rahimi G, Hescheler J & Wartenberg M (2000) Role of reactive oxygen species and 
phosphatidylinositol 3-kinase in cardiomyocyte differentiation of embryonic stem cells. 
FEBS letters 476: 218–23 
Schrader M & Fahimi HD (2006) Peroxisomes and oxidative stress. Biochimica et biophysica 
acta 1763: 1755–66 
Seyde W & Longnecker D (1986) Cerebral oxygen tension in rats during deliberate 
hypotension with sodium nitroprusside, 2-chloroadenosine, or deep isoflurane 
anesthesia. Anesthesiology 64: 480–485 
Shibutani S, Takeshita T & Grollman AP (1991) Insertion of specific bases during DNA 
synthesis past the oxidation-damaged base 8-oxodG. Nature 349: 431–434 
Sick TJ, Lutz PL, Lamanna JC, Rosenthal M & Lamanna C (1982) Comparative brain 
oxygenation and mitochondrial redox activity in turtles and rats. Journal of applied 
physiology 53: 1354–1359 
Sidorenko VS, Grollman AP, Jaruga P, Dizdaroglu M & Zharkov DO (2009) Substrate 
specificity and excision kinetics of natural polymorphic variants and phosphomimetic 
mutants of human 8-oxoguanine-DNA glycosylase. The FEBS journal 276: 5149–62 
Simon MC & Keith B (2008) The role of oxygen availability in embryonic development and 
stem cell function. Nature reviews. Molecular cell biology 9: 285–96 
Simsek D, Furda A, Gao Y, Artus J, Brunet E, Hadjantonakis AK, Van Houten B, Shuman S, 
McKinnon PJ & Jasin M (2011) Crucial role for DNA ligase III in mitochondria but not 
in Xrcc1-dependent repair. Nature 471: 245–8 
Slupphaug G, Mol DC, Kavli B, Arvai AS, Krokan HE & Taine JA (1996) A nucleotide-
flipping mechanism from the structure of human uracil-DNA glycosylase bound to 
DNA. Nature 384: 87–92 


Sobol RW, Horton JK, Kühn R, Gu H, Singhel RK, Prasad R, Rajewsky K & Wilson SH 
(1996) Requirement of mammalian DNA polymerase-beta in base-excision repair. 
Nature 379: 183–186 
Sofroniew MV & Vinters HV (2010) Astrocytes: biology and pathology. Acta 
neuropathologica 119: 7–35 
Soppa J (2010) Protein acetylation in archaea, bacteria, and eukaryotes. Archaea 1: 1–9 
Spitzer NC (2006) Electrical activity in early neuronal development. Nature 444: 707–12 
Strauss PR, Beard WA, Patterson TA & Wilson SH (1997) Substrate binding by human 
apurinic/apyrimidinic endonuclease indicates a Briggs-Haldane mechanism. The Journal 
of biological chemistry 272: 1302–7 
Sugahara M, Mikawa T, Kumasaka T, Yamamoto M, Kato R, Fukuyama K, Inoue Y & 
Kuramitsu S (2000) Crystal structure of a repair enzyme of oxidatively damaged DNA, 
MutM (Fpg), from an extreme thermophile, Thermus thermophilus HB8. The EMBO 
journal 19: 3857–69 
Sugo N, Aratani Y, Nagashima Y, Kubota Y & Koyama H (2000) Neonatal lethality with 
abnormal neurogenesis in mice deficient in DNA polymerase beta. The EMBO journal
19: 1397–404 
Takao M, Kanno S, Shiromoto T, Hasegawa R, Ide H, Ikeda S, Sarker AH, Seki S, Xing JZ, 
Le XC, Weinfeld M, Kobayashi K, Miyazaki J, Muijtjens M, Hoeijmakers JHJ, van der 
Horst G, Yasui A & Sarker AH (2002a) Novel nuclear and mitochondrial glycosylases 
revealed by disruption of the mouse Nth1 gene encoding an endonuclease III homolog 
for repair of thymine glycols. The EMBO journal 21: 3486–93 
Takao M, Kanno S-I, Kobayashi K, Zhang Q-M, Yonei S, van der Horst GTJ & Yasui A 
(2002b) A back-up glycosylase in Nth1 knock-out mice is a functional Nei 
(endonuclease VIII) homologue. The Journal of biological chemistry 277: 42205–13 
Takao M, Oohata Y, Kitadokoro K, Kobayashi K, Iwai S, Yasui A, Yonei S & Zhang QM 
(2009) Human Nei-like protein NEIL3 has AP lyase activity specific for single-stranded 
DNA and confers oxidative stress resistance in Escherichia coli mutant. Genes Cells 14:
261–270 
Taverna P & Sedgwick B (1996) Generation of an endogenous DNA-methylating agent by 
nitrosation in Escherichia coli. Journal of bacteriology 178: 5105–11 
Tchous J, Bodepudi V, Shibutani S, Millers J, Grollmanll AP & Johnson F (1994) Substrate 
Specificity of Fpg Protein. The journal of biological chemistry 269: 15318–15324 
Tebbs RS, Flannery ML, Meneses JJ, Hartmann a, Tucker JD, Thompson LH, Cleaver JE & 
Pedersen R a (1999) Requirement for the Xrcc1 DNA base excision repair gene during 
early mouse development. Developmental biology 208: 513–29 


Theriot CA, Hegde ML, Hazra TK & Mitra S (2010) RPA physically interacts with the 
human DNA glycosylase NEIL1 to regulate excision of oxidative DNA base damage in 
primer-template structures. DNA repair 9: 643–52 
Thompson LH & Schild D (2002) Recombinational DNA repair and human disease. 
Mutation research 509: 49–78 
Tokmakov AA, Kurotani A, Takagi T, Toyama M, Shirouzu M, Fukami Y & Yokoyama S 
(2012) Multiple post-translational modifications bear upon heterologous protein 
synthesis. The Journal of biological chemistry In Press:
Tomkinson AE & Mackey ZB (1998) Structure and function of mammalian DNA ligases. 
Mutation research Res 407: 1–9 
Torisu K, Tsuchimoto D, Ohnishi Y & Nakabeppu Y (2005) Hematopoietic tissue-specific 
expression of mouse Neil3 for endonuclease VIII-like protein. J.Biochem. 138: 763–772 
Tremblay M-È, Stevens B, Sierra A, Wake H, Bessis A & Nimmerjahn A (2011) The role of 
microglia in the healthy brain. The Journal of neuroscience 31: 16064–9 
Tsatmali M, Walcott EC, Makarenkova H & Crossin KL (2006) Reactive oxygen species 
modulate the differentiation of neurons in clonal cortical cultures. Molecular and 
cellular neurosciences 33: 345–57 
Tóth-Petróczy A, Simon I, Fuxreiter M & Levy Y (2009) Disordered tails of homeodomains 
facilitate DNA recognition by providing a trade-off between folding and specific 
binding. Journal of the American Chemical Society 131: 15084–5 
Uppu R, Cueto R, Squadrito G, Salgo M & Pryor W (1996) Competitive reactions of 
peroxynitrite with 2’-deoxyguanosine and 7,8-dihydro-8-oxo-2'-deoxyguanosine (8-
oxodG): relevance to the formation of 8-oxodG in DNA exposed to peroxynitrite. Free 
radical biology & medicine 21: 3–7 
Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M & Telser J (2007) Free radicals and 
antioxidants in normal physiological functions and human disease. The international 
journal of biochemistry & cell biology 39: 44–84 
Vartanian V, Lowell B, Minko IG, Wood TG, Ceci JD, George S, Ballinger SW, Corless CL, 
McCullough AK & Lloyd RS (2006) The metabolic syndrome resulting from a knockout 
of the NEIL1 DNA glycosylase. Proceedings of the National Academy of Sciences of the 
United States of America 103: 1864–9 
Varum S, Momcilovi O, Castro C, Ben-Yehudah A, Ramalho-Santos J & Navara CS (2009) 
Enhancement of human embryonic stem cell pluripotency through inhibition of the 
mitochondrial respiratory chain. Stem cell research 3: 142–56 
Vasen HF, Wijnen JT, Menko FH, Kleibeuker JH, Taal BG, Griffioen G, Nagengast FM, 
Meijers-Heijboer EH, Bertario L, Varesco L, Bisgaard ML, Mohr J, Fodde R & Khan 


PM (1996) Cancer risk in families with hereditary nonpolyposis colorectal cancer 
diagnosed by mutation analysis. Gastroenterology 110: 1020–7 
Venitt S (1996) Mechanisms of spontaneous human cancers. Environmental health 
perspectives 104: 633–7 
Verbeek B, Southgate TD, Gilham DE & Margison GP (2008) O6-Methylguanine-DNA 
methyltransferase inactivation and chemotherapy. British medical bulletin 85: 17–33 
Vermeulen W (2011) Dynamics of mammalian NER proteins. DNA repair 10: 760–71 
Vieira HLA, Alves PM & Vercelli A (2011) Modulation of neuronal stem cell differentiation 
by hypoxia and reactive oxygen species. Progress in neurobiology 93: 444–55 
Vik ES, Alseth I, Forsbring M, Helle IH, Morland I, Luna L, Bjørås M & Dalhus B (2012) 
Biochemical mapping of human NEIL1 DNA glycosylase and AP lyase activities. DNA 
repair 11: 766–73 
Visnes T, Doseth B, Pettersen HS, Hagen L, Sousa MML, Akbari M, Otterlei M, Kavli B, 
Slupphaug G & Krokan HE (2009) Uracil in DNA and its processing by different DNA 
glycosylases. Philosophical transactions of the Royal Society of London. Series B, 
Biological sciences 364: 563–8 
Vogt S, Jones N, Christian D, Engel C, Nielsen M, Kaufmann A, Steinke V, Vasen HF, 
Propping P, Sampson JR, Hes FJ & Aretz S (2009) Expanded extracolonic tumor 
spectrum in MUTYH-associated polyposis. Gastroenterology 137: 1976–85.e1–10 
Vuzman D, Azia A & Levy Y (2010) Searching DNA via a “Monkey Bar” mechanism: the 
significance of disordered tails. Journal of molecular biology 396: 674–84 
Wallace SS, Bandaru V, Kathe SD & Bond JP (2003) The enigma of endonuclease VIII. 
DNA Repair 2: 441–453 
Wallace SS, Murphy DL & Sweasy JB (2012) Base excision repair and cancer. Cancer letters
In Press:
Wanders RJA & Waterham HR (2006) Biochemistry of mammalian peroxisomes revisited. 
Annual review of biochemistry 75: 295–332 
Wang W, Esbensen Y, Kunke D, Suganthan R, Rachek L, Bjørås M & Eide L (2011) 
Mitochondrial DNA damage level determines neural stem cell differentiation fate. The 
Journal of neuroscience 31: 9746–51 
Wang W, Osenbroch P, Skinnes R, Esbensen Y, Bjørås M & Eide L (2010) Mitochondrial 
DNA integrity is essential for mitochondrial maturation during differentiation of neural 
stem cells. Stem cells 28: 2195–204 


Wang Z, Wang F, Tang T & Guo C (2012) The role of PARP1 in the DNA damage response 
and its application in tumor therapy. Frontiers of medicine 6: 156–64 
Ward J (1988) DNA damage produced by ionizing radiation in mammalian cells: identities, 
mechanisms of formation, and reparability. Progress in Nucleic Acid Research and 
Molecular Biology 35: 95–125 
Ward JJ, Sodhi JS, McGuffin LJ, Buxton BF & Jones DT (2004) Prediction and functional 
analysis of native disorder in proteins from the three kingdoms of life. Journal of 
molecular biology 337: 635–45 
Wardman P & Chandeias LP (1996) Fenton chemistry: an introduction. Radiation Research
145: 523–31 
Watson J & Crick F (1953) Molecular structure of nucleic acids. Nature 171: 737–738 
Weiss JM, Goode EL, Ladiges WC & Ulrich CM (2005) Polymorphic variation in hOGG1 
and risk of cancer: a review of the functional and epidemiologic literature. Molecular 
carcinogenesis 42: 127–41 
Wiederhold L, Leppard JB, Kedar P, Karimi-Busheri F, Rasouli-Nia A, Weinfeld M, 
Tomkinson AE, Izumi T, Prasad R, Wilson SH, Mitra S & Hazra TK (2004) AP 
Endonuclease-Independent DNA Base Excision Repair in Human Cells. Molecular cell
15: 209–220 
Xiao W & Samson L (1993) In vivo evidence for endogenous DNA alkylation damage as a 
source of spontaneous mutation in eukaryotic cells. Proceedings of the National 
Academy of Sciences of the United States of America 90: 2117–21 
Xie Y, Yang H, Cunanan C, Okamoto K, Shibata D, Pan J, Barnes DE, Lindahl T, McIlhatton 
M, Fishel R & Miller H (2004) Deficiencies in Mouse Myh and Ogg1 Result in Tumor 
Predisposition and G to T Mutations in Codon 12 of the K-Ras Oncogene in Lung 
Tumors. Cancer Research 64: 3096–3102 
Yang I, Han SJ, Kaur G, Crane C & Parsa AT (2010) The role of microglia in central nervous 
system immunity and glioma immunology. Journal of clinical neuroscience 17: 6–10 
Yang SW, Burgin AB, Huizenga BN, Robertson CA, Yao KC & Nash HA (1996) A 
eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and 
type I topoisomerases. Proceedings of the National Academy of Sciences of the United 
States of America 93: 11534–9 
Yoder KE, Espeseth A, Wang X, Fang Q, Russo MT, Lloyd RS, Hazuda D, Sobol RW & 
Fishel R (2011) The base excision repair pathway is required for efficient lentivirus 
integration. PloS one 6: e17862 


Zahn KE, Wallace SS & Doublié S (2011) DNA polymerases provide a canon of strategies 
for translesion synthesis past oxidatively generated lesions. Current opinion in 
structural biology 21: 358–69 
Zhao C, Deng W & Gage FH (2008) Mechanisms and functional implications of adult 
neurogenesis. Cell 132: 645–60 
Zhao X, Krishnamurthy N, Burrows CJ & David SS (2010) Mutation versus repair: NEIL1 
removal of hydantoin lesions in single-stranded, bulge, bubble, and duplex DNA 
contexts. Biochemistry 49: 1658–66 
Zharkov DO, Golan G, Gilboa R, Fernandes AS, Gerchman SE, Kycia JH, Rieger R a, 
Grollman AP & Shoham G (2002) Structural analysis of an Escherichia coli 
endonuclease VIII covalent reaction intermediate. The EMBO journal 21: 789–800 
Zharkov DO, Rieger RA, Iden CR & Grollman AP (1997) NH2-terminal proline acts as a 
nucleophile in the glycosylase/AP-lyase reaction catalyzed by Escherichia coli 
formamidopyrimidine-DNA glycosylase (Fpg) protein. Journal of Biological Chemistry
272: 5335–5341 
Zharkov DO, Rosenquist T a, Gerchman SE & Grollman a P (2000) Substrate specificity and 
reaction mechanism of murine 8-oxoguanine-DNA glycosylase. The Journal of 
biological chemistry 275: 28607–17 
Zharkov DO, Shoham G & Grollman AP (2003) Structural characterization of the Fpg family 
of DNA glycosylases. DNA Repair 2: 839–862 
Zhou H, Xu M, Huang Q, Gates AT, Zhang XD, Castle JC, Stec E, Ferrer M, Strulovici B, 
Hazuda DJ & Espeseth AS (2008) Genome-scale RNAi screen for host factors required 
for HIV replication. Cell Host.Microbe 4: 495–504 
Zhou W & Doetsch PW (1993) Effects of abasic sites and DNA single-strand breaks on 
prokaryotic RNA polymerases. Proceedings of the National Academy of Sciences of the 
United States of America 90: 6601–5 
66 
 
ERRATA 
 
 
Paper II, Figure 2b: Part of NEIL3 model is missing. Corrected figure is displayed below 
 
Paper II, Figure 2c: ‘Leu81’ corrected to ‘Lys81’ 
 
Paper III, Figure 4, correction of numbering: a→a+b, b→c 
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